( (TITLE (S (NP-SBJ (NP (NN Mutation)) (PP-LOC (IN at) (NP (DT the) (NN Evi1) (NN Locus))) (PP-LOC (IN in) (NP (NN Junbo) (NNS Mice)))) (VP (VBZ Causes) (NP (NP (NN Susceptibility)) (PP (IN to) (NP (NN Otitis) (NN Media))))))) )
( (HEADING (NP (NN Abstract))) )
( (S (NP-SBJ-1 (NP (NP (NN Otitis) (NNS media)) (-LRB- -LRB-) (NP (NN OM))) (-RRB- -RRB-) (, ,) (NP (NP (NN inflammation)) (PP (IN of) (NP (DT the) (JJ middle) (NN ear))))) (, ,) (VP (VBZ remains) (S (NP-SBJ-1 (-NONE- *)) (NP-PRD (NP (DT the) (ADJP (RBS most) (JJ common)) (NN cause)) (PP (IN of) (NP (NP (NN hearing) (NN impairment)) (PP-LOC (IN in) (NP (NNS children)))))))) (. .)) )
( (S (NP-SBJ (PRP It)) (VP (VBZ is) (ADVP (RB also)) (NP-PRD (NP (DT the) (ADJP (RBS most) (JJ common)) (NN cause)) (PP (IN of) (NP (NN surgery))) (PP-LOC (IN in) (NP (NP (NNS children)) (PP-LOC (IN in) (NP (DT the) (JJ developed) (NN world))))))) (. .)) )
( (S (S (NP-SBJ (EX There)) (VP (VBZ is) (NP-PRD (NP (NN evidence) (SBAR-3 (-NONE- *ICH*))) (PP (IN from) (NP (NP (NNS studies)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN population)) (CC and) (NP (NN mouse) (NNS models)))))) (SBAR-3 (IN that) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ significant) (JJ genetic) (NN component)) (VP (VBG predisposing) (PP (IN to) (NP (NN OM))))))))))) (, ,) (S (ADVP (RB yet)) (NP-SBJ-1 (NP (NN nothing)) (PP-2 (-NONE- *ICH*))) (VP (VBZ is) (VP (VBN known) (NP-1 (-NONE- *)) (PP-2 (IN about) (NP (NP (DT the) (VBG underlying) (JJ genetic) (NNS pathways)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NNS humans))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD identified) (NP (NP (NP (DT an) (ADJP (NP (NN N) (HYPH -) (NN ethyl) (HYPH -) (NN N) (HYPH -) (NN nitrosourea)) (HYPH -) (VBN induced)) (JJ dominant) (NN mouse) (JJ mutant)) (NP (NN Junbo))) (PP (IN with) (NP (NP (NN hearing) (NN loss)) (PP (IN due) (IN to) (NP (NP (JJ chronic) (JJ suppurative) (NN OM)) (CC and) (NP (NN otorrhea)))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBZ develops) (PP (IN from) (NP (NP (JJ acute) (NN OM)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ arises) (ADVP-TMP (RB spontaneously)) (PP-TMP (IN in) (NP (DT the) (JJ postnatal) (NN period))) (, ,) (SBAR-ADV (IN with) (S (NP-SBJ (NP (NP (DT the) (NN age)) (PP (IN of) (NP (NN onset)))) (CC and) (NP (JJ early) (NN severity))) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NP (NP (DT the) (JJ microbiological) (NN status)) (PP (IN of) (NP (DT the) (NNS mice)))) (CC and) (NP (PRP$ their) (NN air) (NN quality))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN identified) (NP (NP (DT the) (JJ causal) (NN mutation)) (, ,) (NP (NP (DT a) (JJ missense) (NN change)) (PP-LOC (IN in) (NP (NP (DT the) (ADJP (NN C) (HYPH -) (JJ terminal)) (NML (NN zinc) (NN finger)) (NN region)) (PP (IN of) (NP (NP (DT the) (NN transcription) (NN factor)) (NP (NN Evi1)))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN protein)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NML (JJ middle) (NN ear)) (ADJP (JJ basal) (JJ epithelial)) (NNS cells)) (, ,) (NP (NNS fibroblasts)) (, ,) (CC and) (NP (NN neutrophil) (NNS leukocytes)))) (PP-TMP (IN at) (NP (NP (JJ postnatal) (NN day) (NML (CD 13) (CC and) (CD 21))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ (JJ inflammatory) (NNS changes)) (VP (VBP are) (ADVP-PRD (RB underway)) (ADVP-TMP-2 (-NONE- *T*))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NML (NN identification) (CC and) (NN characterization))) (PP (IN of) (NP (DT the) (NNP Junbo) (NN mutant)))) (VP (VP (VBZ elaborates) (NP (NP (DT a) (JJ novel) (NN role)) (PP (IN for) (NP (NN Evi1))) (PP (IN in) (NP (JJ mammalian) (NN disease))))) (CC and) (VP (VBZ implicates) (NP (DT a) (JJ new) (NN pathway)) (PP (IN in) (NP (NP (JJ genetic) (NN predisposition)) (PP (IN to) (NP (NN OM))))))) (. .)) )
( (HEADING (NP (NN Synopsis))) )
( (S (NP-SBJ (NP (NP (NN Otitis) (NNS media)) (-LRB- -LRB-) (NP (NN OM))) (-RRB- -RRB-) (, ,) (NP (NP (NN inflammation)) (PP (IN of) (NP (DT the) (JJ middle) (NN ear))))) (, ,) (VP (VBZ is) (NP-PRD (NP (DT the) (ADJP (RBS most) (JJ common)) (NN cause)) (PP (IN of) (NP (NN deafness))) (PP-LOC (IN in) (NP (NNS children))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (NP (JJ acute) (NNS episodes)) (PP (IN of) (NP (NN OM))) (PP-LOC (IN in) (NP (NNS children)))) (VP (VBP are) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NML (JJ middle) (NN ear)) (NNS infections))))))) (, ,) (PP (IN in) (NP (NP (DT a) (JJ substantial) (NN portion)) (PP (IN of) (NP (NNS cases))))) (NP-SBJ (NP (NP (JJ recurrent) (NNS episodes)) (PP (IN of) (NP (NN OM)))) (, ,) (CC or) (NP (DT a) (JJ chronic) (JJ suppurative) (NN OM))) (, ,) (VP (MD will) (VP (VB develop))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBZ is) (NP-PRD (NP (NN evidence) (SBAR-1 (-NONE- *ICH*))) (PP (IN from) (NP (NP (JJ genetic) (NNS studies)) (PP (IN of) (NP (JJ human) (NNS families))))) (SBAR-1 (IN that) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ significant) (JJ genetic) (NN component)) (VP (VBG contributing) (PP (IN to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (ADJP (JJ recurrent) (CC and) (JJ chronic)) (NNS forms)) (PP (IN of) (NP (NN OM)))))))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (NP (DT the) (NNS genes)) (VP (VBN involved) (NP (-NONE- *)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN identified) (NP-1 (-NONE- *))))) (. .)) )
( (S (NP-SBJ (DT The) (NNS authors)) (VP (VBP have) (VP (VBN identified) (CC and) (VBN characterized) (NP (NP (NN mouse) (NNS mutants)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP demonstrate) (NP (JJ chronic) (NN OM)))))) (PP (IN as) (NP (NP (DT a) (NN route)) (PP (IN to) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG identifying) (NP (NP (NNS genes)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN with) (NP (NN OM)))))))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN study)) (VP (VBZ describes) (NP (NP (NP (CD one) (NN mutant)) (, ,) (NP (NN Junbo))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ shares) (NP (JJ many) (NNS features)) (PP (IN with) (NP (JJ human) (NN OM)))))))) (. .)) )
( (S (NP-SBJ (NN Junbo)) (VP (VBZ develops) (NP (NP (DT an) (JJ acute) (NN OM)) (SBAR-2 (-NONE- *ICH*))) (PP-TMP (VBG following) (NP (NN birth))) (SBAR-2 (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP-TMP (RB subsequently)) (VP (VBZ develops) (PP (IN into) (NP (NP (DT a) (JJ chronic) (JJ suppurative) (NN form)) (PP (IN of) (NP (NN OM))))))))) (. .)) )
( (S (NP-SBJ (NN Junbo)) (VP (VBZ carries) (NP (NP (DT a) (NN mutation)) (PP (IN in) (NP (NP (DT the) (NML (NN transcription) (NN factor)) (NN gene)) (, ,) (NP (NN Evi1)))))) (. .)) )
( (S (NP-SBJ-1 (NN Evi1)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NN cell) (NNS types))))) (PP-LOC (IN in) (NP (DT the) (NML (JJ middle) (NN ear)) (NN lining))) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ (JJ inflammatory) (NNS changes)) (VP (VBP are) (ADJP-PRD (JJ underway)) (ADVP-TMP-2 (-NONE- *T*))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN identification)) (PP (IN of) (NP (DT the) (NN Junbo) (NN mutation)))) (VP (VBZ implicates) (NP (NP (DT a) (JJ new) (NN gene)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NP (NN predisposition)) (PP (IN to) (NP (NN OM)))))))) (. .)) )
( (HEADING (NP (NN Introduction))) )
( (S (NP-SBJ-2 (NP (NP (NN Otitis) (NNS media)) (-LRB- -LRB-) (NP (NN OM))) (-RRB- -RRB-) (, ,) (NP (NP (NN inflammation)) (PP (IN of) (NP (DT the) (JJ middle) (NN ear))))) (, ,) (VP (VBZ remains) (S (NP-SBJ-2 (-NONE- *)) (NP-PRD (NP (DT the) (ADJP (RBS most) (JJ common)) (NN cause)) (PP (IN of) (NP (NP (VBG hearing) (NN impairment)) (PP-LOC (IN in) (NP (NNS children))))))) (PRN (-LRB- [) (NP (CD 1) (, ,) (CD 2)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Acute) (NNS episodes)) (PP (IN of) (NP (NN OM))) (PP-LOC (IN in) (NP (NNS infants) (CC and) (NNS children)))) (VP (VBP are) (ADVP-TMP (RBS most) (RB often)) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NML (JJ middle) (NN ear)) (NNS infections)) (VP (VBG involving) (NP (DT the) (NNS pathogens) (NML (NML (NNP Streptococcus) (NNP pneumoniae)) (CC and) (NML (NNP Haemophilus) (NNP influenzae))))))) (PRN (-LRB- [) (NP (CD 3)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (JJ Prolonged) (NN stimulation)) (PP (IN of) (NP (DT the) (JJ inflammatory) (NN response))) (, ,) (PP (IN along) (PP (IN with) (NP (JJ poor) (JJ mucociliary) (NN clearance))))) (, ,) (VP (MD can) (ADVP (RB also)) (VP (VB lead) (PP (IN to) (NP (NP (DT the) (NN persistence)) (PP (IN of) (NP (NML (JJ middle) (NN ear)) (NN fluid))))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG giving) (NP (NN rise)) (PP (IN to) (NP (NP (DT the) (JJ clinical) (NN presentation)) (PP (IN of) (NP (NP (NN otitis) (NNS media)) (PP (IN with) (NP (NN effusion))))))))) (PRN (-LRB- [) (NP (CD 2)) (-RRB- ])))) (. .)) )
( (S (PP-LOC (IN In) (NP (NP (DT a) (JJ substantial) (NN portion)) (PP (IN of) (NP (NNS children))))) (, ,) (NP-SBJ (NP (NP (JJ recurrent) (NNS episodes)) (PP (IN of) (NP (NN OM)))) (CC or) (NP (DT a) (JJ chronic) (JJ suppurative) (NN OM))) (VP (MD will) (VP (VB develop))) (. .)) )
( (S (NP-SBJ (NP (NP (DT The) (JJ high) (NN prevalence)) (PP (IN of) (NP (DT the) (NN disease)))) (, ,) (VP (VBN coupled) (NP (-NONE- *)) (PP (IN with) (NP (PRP$ its) (ADJP (JJ recurrent) (CC and) (JJ chronic)) (NN nature))))) (, ,) (VP (VBZ accounts) (PP (IN for) (NP (NP (DT the) (JJ large) (NN number)) (PP (IN of) (NP (NP (NNS tympanostomies)) (VP (VBN undertaken) (NP (-NONE- *)) (PP-LOC (IN in) (NP (VBN affected) (NNS children))))))))) (. .)) )
( (S (NP-SBJ (NN OM)) (VP (VBZ is) (ADVP-TMP (RB still)) (NP-PRD (NP (DT the) (ADJP (RBS most) (JJ common)) (NN cause)) (PP (IN of) (NP (NN surgery))) (PP-LOC (IN in) (NP (NP (NNS children)) (PP-LOC (IN in) (NP (DT the) (VBN developed) (NN world))))))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBZ is) (ADVP-TMP (RB still)) (NP-PRD (NP (JJ considerable) (NN debate)) (PP (IN over) (NP (NP (NP (DT the) (NN etiology)) (PP (IN of) (NP (NN OM)))) (CC and) (NP (DT the) (VBG underlying) (JJ pathological) (NNS mechanisms))))) (PRN (-LRB- [) (NP (CD 2)) (-RRB- ]))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (NN risk) (NNS factors)) (PP (IN for) (NP (NN OM)))) (VP (VBP include) (NP (NP (JJ craniofacial) (NNS abnormalities)) (, ,) (NP (JJ impaired) (JJ mucocilliary) (NN function)) (, ,) (CC and) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT an) (JJ inflammatory) (NN stimulus)) (, ,) (PP (JJ such) (IN as) (NP (NNS bacteria)))))))) (. .)) )
( (S (S (NP-SBJ (EX There)) (VP (VBZ is) (NP-PRD (NP (NN evidence) (SBAR-3 (-NONE- *ICH*))) (PP (IN from) (NP (NP (NNS studies)) (PP (IN of) (NP (NP (DT the) (JJ human) (NN population)) (CC and) (NP (NN mouse) (NNS models)))))) (SBAR-3 (IN that) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ significant) (JJ genetic) (NN component)) (VP (VBG predisposing) (PP (IN to) (NP (ADJP (JJ recurrent) (CC or) (JJ chronic)) (NN OM))))))))) (PRN (-LRB- [) (NP (NP (CD 4)) (PP (SYM –) (NP (CD 7)))) (-RRB- ])))) (, ,) (S (ADVP (RB yet)) (NP-SBJ-1 (NP (JJ little)) (PP-2 (-NONE- *ICH*))) (VP (VBZ is) (VP (VBN known) (NP-1 (-NONE- *)) (PP-2 (IN about) (NP (NP (DT the) (VBG underlying) (JJ genetic) (NNS pathways)) (VP (VBN involved) (NP (-NONE- *)))))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ-2 (JJ several) (JJ inbred) (NNS strains)) (VP (VBP are) (VP (VBN predisposed) (NP-2 (-NONE- *)) (PP (IN to) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN OM))))))))) (, ,) (NP-SBJ-1 (PRP$ their) (NML (NML (JJ genetic) (NN analysis)) (CC and) (NML (NN utility)))) (VP (VBZ is) (VP (VBN compounded) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (JJ complex) (JJ genetic) (NNS bases)) (CC and) (NP (NP (DT the) (JJ low) (NN penetrance)) (PP (IN of) (NP (DT the) (NN phenotype)))))) (PRN (-LRB- [) (NP (CD 6)) (-RRB- ])))) (. .)) )
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (EX there)) (VP (VBP are) (NP-PRD (NP (JJ several) (NN mouse) (NNS mutants)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP demonstrate) (NP (DT an) (NN OM) (NN phenotype)))))))) (, ,) (CC but) (S (NP-SBJ (DT the) (NN OM)) (VP (VBZ develops) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT a) (JJ complex) (NN syndrome)) (PP (IN with) (NP (NP (DT a) (JJ wide) (NN spectrum)) (PP (IN of) (NP (NNS phenotypes))))))))) (PRN (-LRB- [) (NP (CD 6)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (S-1 (-NONE- *EXP*))) (VP (MD will) (VP (VB be) (ADJP-PRD (JJ important)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (CC and) (VB characterize) (NP (NP (DT the) (NNS genes)) (VP (VBG underlying) (NP (NP (ADJP (RB highly) (JJ penetrant)) (NN mouse) (NNS mutants)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VP (VBP develop) (NP (NN OM)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ other) (JJ diverse) (NN pathology)))))) (CC and) (VP (VBP represent) (NP (NP (JJ appropriate) (NNS models)) (PP (IN for) (NP (NP (NN OM)) (PP-LOC (IN in) (NP (DT the) (JJ human) (NN population)))))))))))))))))) (. .)) )
( (S (NP-SBJ (NML (JJ Large) (HYPH -) (NN scale)) (ADJP (NN phenotype) (HYPH -) (VBN driven)) (NML (NN mouse) (NML (NML (NN ENU)) (-LRB- -LRB-) (NML (NN N) (HYPH -) (NN ethyl) (HYPH -) (NN N) (HYPH -) (NN nitrosourea))) (-RRB- -RRB-) (NN mutagenesis)) (NNS programs)) (VP (VBP provide) (NP (NP (DT a) (JJ rich) (NN source)) (PP (IN of) (NP (NP (JJ novel) (NN mutant) (NNS phenotypes)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (NP-PRD (NP (DT the) (NN basis)) (PP (IN for) (NP (JJ systematic) (NNS efforts) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB identify) (NP (NP (DT the) (JJ genetic) (NN basis)) (PP (IN for) (NP (JJ diverse) (NN disease) (NNS states)))))))))))))))) (PRN (-LRB- [) (NP (NP (CD 8)) (PP (SYM –) (NP (CD 10)))) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (CD One) (JJ such) (NN screen)) (PP-LOC (IN at) (NP (NNP MRC) (NNP Harwell)))) (, ,) (VP (VBD recovered) (NP (NP (DT a) (JJ large) (NN number)) (PP (IN of) (NP (NP (JJ mutant) (NNS phenotypes)) (VP (VBG representing) (NP (ADJP (NN ENU) (HYPH -) (VBN induced)) (NNS mutations)))))) (PP-LOC (IN at) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (JJ novel) (NNS loci)) (PP-LOC (IN in) (NP (DT the) (JJ mammalian) (NN genome))))))) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ-1 (NN Mouse) (NNS models)) (VP (VP (VBP have) (NP-2 (-NONE- *RNR*))) (CC and) (VP (VBP continue) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB play) (NP-2 (-NONE- *RNR*)))))) (NP-2 (NP (DT an) (JJ important) (NN role)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG studying) (NP (NP (DT the) (JJ genetic) (NNS causes)) (PP (IN of) (NP (NN hearing) (NN impairment))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NN number)) (PP (IN of) (NP (NNS mutations)))) (VP (VP (VBP have) (VP (VBN been) (VP (VBN cloned) (NP-1 (-NONE- *))))) (CC and) (VP (VBP have) (VP (VBN provided) (NP (PRP us)) (PP (IN with) (NP (NP (JJ several) (JJ profound) (NNS insights)) (PP (IN into) (NP (NP (DT the) (JJ critical) (NN proteins)) (ADJP (VBN involved) (PP (IN with) (NP (NP (DT the) (NML (NN development) (CC and) (NN function))) (PP (IN of) (NP (DT the) (JJ auditory) (NN apparatus))) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (CC both) (DT the) (ADJP (JJ middle) (CC and) (JJ inner)) (NNS ears)))))))))))) (PRN (-LRB- [) (NP (CD 11) (, ,) (CD 12)) (-RRB- ]))))) (. .)) )
( (S (ADVP (RB Nevertheless)) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ clear)) (SBAR-1 (IN that) (S (NP-SBJ (PRP we)) (VP (VBP do) (RB not) (VP (VB possess) (NP (NP (NN mouse) (NNS mutants)) (PP (IN for) (NP (NP (DT all) (NML (NNS loci) (CC and) (NNS pathways))) (ADJP (RB potentially) (VBN involved) (PP (IN in) (NP (NN hearing) (NN impairment)))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP report) (NP (NP (DT the) (NN characterization)) (PP (IN of) (NP (NP (NP (DT a) (JJ new) (NN mutant)) (, ,) (NP (NN Junbo))) (, ,) (VP (VBN identified) (NP (-NONE- *)) (PP (IN in) (NP (DT the) (NNP Harwell) (NN mutagenesis) (NN program))) (PP (IN as) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG having) (NP (DT a) (NN deafness) (NN phenotype)))))))))) (. .)) )
( (S (NP-SBJ (NN Junbo)) (VP (VBZ is) (NP-PRD (NP (NP (DT a) (NN model)) (PP (IN of) (NP (NN OM)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ shares) (NP (JJ many) (NNS features)) (PP (IN with) (NP (DT the) (JJ human) (NN condition)))))))) (. .)) )
( (S (NP-SBJ (JJ Acute) (NN OM)) (VP (VP (VBZ arises) (ADVP-MNR (RB spontaneously)) (PP-TMP (IN in) (NP (DT the) (JJ postnatal) (NN period)))) (CC and) (VP (VBZ develops) (PP (IN into) (NP (NP (JJ chronic) (JJ suppurative) (NN OM)) (PP (IN with) (NP (NN otorrhea))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (VBG underlying) (JJ molecular) (NN basis)) (PP (IN of) (NP (DT this) (NN phenotype)))) (VP (VBZ has) (VP (VBN been) (VP (VBN identified) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (DT a) (NN mutation)) (PP (IN in) (NP (DT the) (NN Evi1) (NN transcription) (NN factor))))) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG causing) (NP (NP (DT a) (JJ nonconservative) (NN Asn763Ile) (NN change)) (PP (IN in) (NP (NP (DT the) (NN second)) (PP (IN of) (NP (NP (DT the) (CD two) (NML (NN zinc) (HYPH -) (NN finger)) (NNS domains)) (PP-LOC (IN in) (NP (DT this) (NN protein))))))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN Junbo) (NN mouse)) (VP (VP (VBZ highlights) (NP (NP (DT a) (JJ new) (NN role)) (PP (IN for) (NP (NP (DT the) (NN transcription) (NN factor)) (NP (NN Evi1)))))) (CC and) (VP (VBZ provides) (NP (NP (DT the) (JJ first) (NN evidence)) (PP (IN for) (NP (NP (DT the) (JJ genetic) (NNS pathways)) (ADJP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN etiology)) (PP (IN of) (NP (DT this) (JJ complex) (NN childhood) (NN disease))))))))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (HEADING (NP (NP (NN Identification) (, ,) (NN Mapping) (, ,) (CC and) (NN Cloning)) (PP (IN of) (NP (DT the) (NN Junbo) (NN Mutation))))) )
( (S (NP-SBJ (DT An) (NML (NN ENU) (NN mutagenesis)) (NN screen) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ]))) (VP (VBD identified) (NP (NP (NP (DT a) (JJ new) (JJ dominant) (NN mutant)) (, ,) (NP (NP (NN Junbo)) (-LRB- -LRB-) (NP (NN Jbo)))) (-RRB- -RRB-) (, ,) (PP (IN with) (NP (NN hearing) (NN loss))))) (. .)) )
( (S (NP-SBJ (NP (JJ Preliminary) (NN phenotyping)) (VP (VBG using) (NP (NP (DT a) (NML (VB click) (HYPH -) (NN box)) (NN test) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Materials) (CC and) (NNS Methods)))) (-RRB- -RRB-))) (PP (IN of) (NP (NP (DT an) (ADJP (NN age) (HYPH -) (VBN matched)) (NN cohort)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (DT the) (NN founder) (NN mouse))))))))) (VP (VBD indicated) (SBAR (IN that) (S (NP-SBJ (NNS mice)) (VP (VBD demonstrated) (NP (DT a) (NN hearing) (NN loss)) (PP-TMP (IN at) (NP (QP (SYM ~) (CD 40)) (NML (NML (NML (NNS d)) (PP-TMP (IN after) (NP (NN birth)))) (-LRB- -LRB-) (NML (NNS DAB)) (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD used) (NP (NP (NP (DT a) (VBG pooling) (NN strategy)) (VP (VBG employing) (NP (NP (NN DNA)) (PP (IN from) (NP (VBN affected) (NNS mice)))))) (CC and) (NP (ADJP (NN genome) (HYPH -) (JJ wide)) (JJ fluorescent) (ADJP (NP (JJ simple) (NN sequence) (NN length) (NN polymorphism)) (HYPH -) (VBN based)) (NN screening) (PRN (-LRB- [) (NP (CD 9) (, ,) (CD 13)) (-RRB- ])))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB provide) (NP (NP (DT an) (JJ initial) (NN map) (NN position)) (PP (IN for) (NP (DT the) (NN Jbo) (NN mutation))) (PP-LOC (IN on) (NP (NN Chromosome) (CD 3)))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN map) (NN position)) (VP (VBD was) (ADVP (RB further)) (VP (VBN refined) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (JJ additional) (VBN affected) (NNS animals)))) (PP (IN to) (NP (NP (DT an) (NML (QP (RB approximately) (CD 1.5)) (HYPH -) (NN Mb)) (NN region)) (VP (VBN delineated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN Eif5a2) (NN locus)) (CC and) (NP (NN microsatellite) (NN marker) (NN D3Mit178))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Direct) (NN sequence) (NN analysis)) (PP (IN of) (NP (NP (NN coding) (NNS regions)) (PP (IN within) (NP (DT this) (NN interval)))))) (VP (VBD identified) (NP (NP (DT an) (NN A2288T) (NN transversion)) (PP (IN in) (NP (DT the) (NN Evi1) (NN locus)))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG causing) (NP (NP (DT a) (JJ nonconservative) (NN Asn763Ile) (NN change)) (PP-LOC (IN in) (NP (NP (DT the) (NN second)) (PP (IN of) (NP (NP (DT the) (CD two) (NML (NN zinc) (HYPH -) (NN finger)) (NNS domains)) (PP-LOC (IN in) (NP (DT this) (NN protein)))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 1A) (CC and) (NN 1B))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (DT No) (JJ other) (NN sequence) (NNS changes)) (VP (VBD were) (VP (VBN identified) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT any) (JJ other) (NN coding) (NNS sequences)) (PP (IN within) (NP (NP (DT the) (JJ minimal) (JJ nonrecombinant) (NN region)) (VP (VBG containing) (NP (DT the) (NN mutation))))))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (HEADING (S (NP-SBJ-1 (DT The) (NN Evi1) (NN Gene)) (VP (VBZ Is) (VP (VBN Mutated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN Junbo) (NNS Mice))))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (NN Sequence) (NN analysis)) (PP (IN of) (NP (DT the) (NN Evi1) (NN locus))) (PP-LOC (IN in) (NP (NP (NML (NN BALB) (HYPH /) (NN c)) (NML-1 (-NONE- *RNR*))) (, ,) (NP (NML (NN C3H) (HYPH /) (NN HeN)) (NML-1 (-NONE- *RNR*))) (, ,) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (JJ adult) (NML-1 (-NONE- *RNR*))) (, ,) (CC and) (NP (NML (NN Jbo) (HYPH /) (NN Jbo)) (JJ embryonic) (NML-1 (-NONE- *RNR*))) (NML-1 (NN DNA)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (DT An) (NN A2318T) (NN transversion)) (SBAR-2 (-NONE- *ICH*))) (VP (VBZ is) (VP (VBN detected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (NN Jbo) (HYPH /) (NN Jbo))) (NNS mutants))) (SBAR-2 (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ is) (RB not) (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (DT either) (JJ parental) (NNS substrains)))))))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NN Schematic)) (PP (IN of) (NP (DT the) (NN EVI1) (NN peptide))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (CD Ten) (NML (NN zinc) (NN finger)) (NNS motifs)) (VP (VBP are) (VP (VBN clustered) (NP-1 (-NONE- *)) (PP (IN into) (NP (NP (CD two) (NML (NN DNA) (HYPH -) (VBG binding)) (NNS domains)) (, ,) (NP (NN ZF1) (CC and) (NN ZF2)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN EVI1)) (VP (VP (VBZ contains) (NP=1 (DT a) (ADJP (NN proline) (HYPH -) (JJ rich)) (NN repressor) (NN domain)) (PP-LOC=2 (IN between) (NP (NP (DT the) (CD two) (NNS sets)) (PP (IN of) (NP (NN zinc) (NNS fingers)))))) (CC and) (VP (NP=1 (DT a) (ADJP (RB highly) (JJ acidic)) (NN domain)) (PP-LOC=2 (IN at) (NP (DT the) (NN C) (HYPH -) (NN terminus))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (VBN Expanded) (NN peptide) (NN sequence)) (PP (IN across) (NP (DT the) (JJ ninth) (NML (NN zinc) (NN finger)) (NN motif)))) (VP (VBZ shows) (NP (NP (DT the) (JJ high) (NN degree)) (PP (IN of) (NP (NP (NN conservation)) (PP (IN of) (NP (DT this) (NN region))))) (PP (IN between) (NP (NP (JJ orthologous) (NN proteins)) (PP (IN from) (NP (NP (JJ different) (NNS species)) (: :) (NP (NP (NNP Mus) (NNP musculus) (PRN (-LRB- -LRB-) (NP (NN P14404)) (-RRB- -RRB-))) (, ,) (NP (NNP Rattus) (NNP norvegicus) (PRN (-LRB- -LRB-) (NP (NN ENSRNOG00000012645)) (-RRB- -RRB-))) (, ,) (NP (NNP Homo) (NNP sapien) (PRN (-LRB- -LRB-) (NP (NN Q03112)) (-RRB- -RRB-))) (, ,) (NP (NNP Danio) (NNP rerio) (PRN (-LRB- -LRB-) (NP (NN ENSDARP00000008993)) (-RRB- -RRB-))) (, ,) (NP (NNP Fugu) (NNP rubrides) (PRN (-LRB- -LRB-) (NP (NN ENSDARP00000008993)) (-RRB- -RRB-))) (, ,) (NP (NNP Drosophila) (NNP melanogaster) (PRN (-LRB- -LRB-) (NP (NN CG31753)) (-RRB- -RRB-))) (, ,) (NP (NNP Caenorhabditis) (NNP elegans) (PRN (-LRB- -LRB-) (NP (NN R53.3a)) (-RRB- -RRB-)))))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ-1 (NN Contact) (NNS residues)) (VP (VBP are) (VP (VBN highlighted) (NP-1 (-NONE- *)) (PP (IN in) (NP (JJ yellow)))))) (, ,) (S (NP-SBJ-2 (NP (DT the) (NN position)) (PP (IN of) (NP (DT the) (NN Junbo) (NN mutation)))) (VP (VBZ is) (VP (VBN highlighted) (NP-2 (-NONE- *)) (PP (IN in) (NP (JJ red)))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (NP-SBJ-1 (JJ Extra) (NNS digits)) (VP (VBP are) (VP (VBN seen) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (NP (DT the) (NNS forelimbs)) (PP (IN of) (NP (CC both) (NML (NN heterozygote) (CC and) (NN homozygote)) (NNS mice))))) (NP-TMP (NN E18.5)) (PRN (-LRB- -LRB-) (NP (JJ white) (NNS arrows)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (S (PP-LOC (IN In) (NP (NNS heterozygotes) (, ,) (PRN (-LRB- -LRB-) (NP (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (JJ middle) (NN panel)) (-RRB- -RRB-)))) (NP-SBJ-1 (DT an) (JJ extra) (NN digit)) (VP (VBZ is) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (DT either) (NN forelimb))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NNS homozygotes) (, ,) (PRN (-LRB- -LRB-) (NP (NN Jbo) (HYPH /) (NN Jbo)) (, ,) (NP (JJ right) (NN panel)) (-RRB- -RRB-))) (VP (VBP have) (NP (JJ extra) (NNS digits)) (PP-LOC (IN on) (NP (DT both) (NNS forelimbs)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (JJ anterior) (NN digit)) (VP (VBZ is) (ADVP-TMP (RB often)) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN size))) (PP-LOC (IN in) (NP (DT the) (NN homozygote) (NNS limbs))) (PRN (-LRB- -LRB-) (NP (JJ red) (NN arrow)) (-RRB- -RRB-)))) (. .))) )
( (CAPTION (FRAG (NP (NML (JJ Wild) (HYPH -) (NN type)) (NNS mice)) (, ,) (NP (JJ left) (NN panel)) (. .))) )
( (S (NP-SBJ-1 (NP (NP (DT A) (NN knockout) (NN allele)) (PP (IN of) (NP (NN Evi1)))) (NP-2 (-NONE- *ICH*))) (VP (VBZ has) (VP (VBN been) (VP (VBN produced) (NP-1 (-NONE- *)) (, ,) (NP-2 (NN Evi1tm1Mmor)) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ (NN Evi1tm1Mmor) (NNS mice)) (VP (VBP carry) (NP (DT a) (VBN targeted) (NN deletion)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG resulting) (PP (IN in) (NP (NP (DT an) (ADJP (NN isoform) (HYPH -) (JJ specific)) (JJ null)) (PP (IN for) (NP (DT the) (JJS longest) (NN Evi1) (NNS transcripts))))))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ-1 (DT the) (NN Δ324) (PRN (-LRB- -LRB-) (NP (JJR shorter)) (-RRB- -RRB-)) (NN isoform) (PRN (-LRB- [) (NP (CD 15) (, ,) (CD 16)) (-RRB- ]))) (VP (VBZ remains) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ unaltered))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN isoform)) (VP (VP (VBZ lacks) (NP (NP (DT the) (JJ final) (CD two) (NML (NN zinc) (HYPH -) (NN finger)) (NNS motifs)) (PP (IN from) (NP (DT the) (ADJP (JJ first) (PRN (-LRB- -LRB-) (ADJP (NN N) (HYPH -) (JJ terminal)) (-RRB- -RRB-))) (NML (NN DNA) (HYPH -) (VBG binding)) (NN domain))))) (CC and) (VP (ADVP-TMP (RB consequently)) (VBZ is) (VP (VBN predicted) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB exhibit) (NP (JJ altered) (NN binding) (NNS abilities)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Characterization)) (PP (IN of) (NP (NP (NN heterozygote) (NNS mice)) (VP (VBG carrying) (NP (DT this) (VBN targeted) (NN mutant)))))) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB uncover) (NP (DT any) (NN phenotype)) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NNS homozygotes)) (VP (VBP show) (NP (NP (JJ prenatal) (NN lethality)) (PP (IN from) (NP (JJ presumptive) (JJ cardiac) (NN failure)))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ]))))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (DT these) (NNS embryos)) (VP (VBD displayed) (NP (NP (NP (JJ widespread) (NN hypocellularity)) (, ,) (PP (ADVP (RBS most) (RB markedly)) (IN of) (NP (DT the) (JJ cortical) (NN mesenchyme)))) (, ,) (NP (NP (VBN retarded) (NN development)) (PP (IN of) (NP (DT the) (ADJP (JJ first) (CC and) (JJ second)) (JJ branchial) (NNS arches)))) (, ,) (CC and) (NP (NP (ADJP (RB severely) (VBN reduced)) (NN vasculature)) (PP (IN of) (NP (DT the) (NN yolk) (NN sac)))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB confirm) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN A2318T) (NN alteration)) (VP (VBN identified) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NN Evi1))))) (VP (VBZ is) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (DT the) (NN Junbo) (NN phenotype)))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD undertook) (NP (DT a) (NN complementation) (NN screen)) (PP-LOC (IN between) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +))) (NNS animals)))) (. .)) )
( (S (S (NP-SBJ-1 (CD 81) (JJ live) (NNS births)) (VP (VBD were) (VP (VBN produced) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NNS crosses)) (PP (IN of) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +))) (NNS mice)))))))) (CC and) (S (NP-SBJ-2 (DT all)) (VP (VBD were) (VP (VBN genotyped) (NP-2 (-NONE- *))))) (. .)) )
( (S (NP-SBJ (NP (NN None)) (PP (IN of) (NP (DT the) (NN progeny)))) (VP (VBD coinherited) (NP (NP (DT the) (NN Evi1tm1Mmor) (NML-1 (-NONE- *RNR*))) (CC and) (NP (DT the) (NN Jbo) (NML-1 (-NONE- *RNR*))) (NML-1 (NNS mutations)))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (NP (DT the) (JJ other) (JJ expected) (NNS genotypes)) (NP-2 (-NONE- *ICH*))) (VP (VBD were) (VP (VBN recovered) (NP-1 (-NONE- *)) (: —) (NP-2 (NP (NN Jbo) (HYPH /) (SYM +) (PRN (-LRB- -LRB-) (NP (CD 38) (NN %)) (-RRB- -RRB-))) (, ,) (NP (NN Evi1tm1Mmor) (HYPH /) (SYM +) (PRN (-LRB- -LRB-) (NP (CD 28) (NN %)) (-RRB- -RRB-))) (, ,) (NP (SYM +) (HYPH /) (SYM +) (PRN (-LRB- -LRB-) (NP (CD 33) (NN %)) (-RRB- -RRB-)))) (: —) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG confirming) (NP (NP (DT the) (NN allelism)) (PP (IN of) (NP (DT the) (NML (NN knockout) (CC and) (NN Junbo)) (NN mutant)))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD established) (NP (NP (NNS intercrosses)) (PP-LOC (IN between) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS animals)))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (ADJP (FW in) (FW vitro)) (NN fertilization)) (CC and) (NP (NP (NN implantation)) (PP-LOC (IN into) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS females))))) (SBAR-PRP (IN as) (S (NP-SBJ (NML (NN Jbo) (HYPH /) (SYM +)) (NNS females)) (VP (VBP undergo) (NP (VBN repeated) (JJ spontaneous) (NN abortion)))))))) (. .)) )
( (S (PP-TMP (IN At) (NP (CD 10.5) (NML (NML (NP (NNS days)) (ADVP (RB postcoitum))) (-LRB- -LRB-) (NML (NNS dpc))))) (-RRB- -RRB-) (, ,) (NP-SBJ (NP (CD 17) (NN %)) (PP (IN of) (NP (NN homozygote) (NNS mice)))) (VP (VBD had) (NP (NP (NP (JJ small) (NN hind) (NNS limbs)) (, ,) (NP (DT a) (JJ large) (JJ pericardial) (NN sac)) (, ,) (CC and) (NP (DT a) (JJ malformed) (NN forebrain))) (, ,) (NP (NP (NNS features)) (VP (VBN demonstrated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN knockout))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ])))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (JJ many) (NNS homozygotes)) (VP (VP (VBD were) (VP (VBN scored) (NP-1 (-NONE- *)) (PP (IN as) (ADJP (JJ normal))) (PP (IN in) (NP (NN appearance))) (PP-TMP (IN at) (NP (NP (DT this) (NML-2 (-NONE- *RNR*))) (CC and) (NP (JJ later) (NML-2 (-NONE- *RNR*))) (NML-2 (NNS stages)))))) (CC and) (VP (VBD proceeded) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB die) (PP-TMP (IN between) (NP (NN E18.5) (CC and) (NN birth))) (, ,) (SBAR-ADV (IN though) (S (NP-SBJ (NNS homozygotes)) (VP (VBD were) (PP-PRD (IN of) (NP (NP (JJ comparable) (NN body) (NN size)) (PP (IN to) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS littermates))))))))))))) (. .)) )
( (S (NP-SBJ (PRP It)) (VP (VBZ appears) (SBAR (IN that) (S (SBAR-ADV (IN though) (S (NP-SBJ (DT some) (JJ homozygote) (NNS embryos)) (VP (MD may) (VP (VB die) (PP-TMP (IN at) (NP (CD 10.5) (NNS dpc))))))) (, ,) (NP-SBJ-3 (NNS others)) (VP (VBP continue) (S (NP-SBJ-3 (-NONE- *)) (VP (TO to) (VP (VB develop) (ADVP-MNR (RB unhindered)) (SBAR-TMP (WHADVP-2 (WRB when)) (S (NP-SBJ-4 (-NONE- *PRO*)) (VP (VBN carried) (NP-4 (-NONE- *)) (PP (IN by) (NP-LGS (DT a) (NML (JJ wild) (HYPH -) (NN type)) (NN mother))) (ADVP-TMP-2 (-NONE- *T*)))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ only) (JJ other) (JJ phenotypic) (NN feature)) (VP (VBN detected) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))))) (VP (VBD was) (NP-PRD (NP (DT an) (JJ extra) (NN digit)) (PP-LOC (IN on) (NP (CD one) (NN forelimb))))) (. .)) )
( (S (NP-SBJ (NML (NN Jbo) (HYPH /) (NN Jbo)) (NNS mice)) (VP (VBP have) (NP (JJ extra) (NNS digits)) (PP-LOC (IN on) (NP (DT both) (NNS forelimbs))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (NN 1C)))) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NP (NN Pathology) (NN Phenotyping)) (PP (IN of) (NP (DT the) (NN Junbo) (NN Mutant))))) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB determine) (NP (NP (DT the) (NN cause)) (PP (IN of) (NP (NP (DT the) (NN deafness) (NN phenotype)) (PP-LOC (IN in) (NP (NN Junbo))))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD performed) (NP (NP (DT an) (JJ initial) (NN examination)) (PP (IN of) (NP (NP (JJ deaf) (JJ adult) (NNS animals)) (CC and) (NP (JJ embryonic) (JJ skeletal) (NNS preparations) (PRN (-LRB- -LRB-) (NP (NP (CD 15.5) (NNS dpc)) (PP (SYM –) (NP (CD 18.5) (NNS dpc)))) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ (DT This)) (VP (VBD revealed) (NP (DT no) (NML (NML (NML (JJ gross) (JJ morphological) (NNS defects)) (PP (IN of) (NP (DT the) (NML (NML (JJ inner) (NN ear)) (CC and) (NML (JJ ossicular) (NN chain)))))) (CC or) (NML (NML (NN ossification)) (PP (IN of) (NP (DT the) (NML (NML (JJ temporal) (NN bone)) (CC and) (NML (JJ tympanic) (NN ring)))))))) (PP-LOC (IN in) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS animals)))) (. .)) )
( (S (NP-SBJ (NP (NN Dissection)) (PP (IN of) (NP (NP (DT the) (NNS bullae)) (PP (IN of) (NP (NP (CD seven) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)) (CC and) (NP (CD four) (NML (SYM +) (HYPH /) (SYM +)) (NNS mice)))))) (PRN (-LRB- -LRB-) (NP (QP (SYM >) (CD 130)) (NNS DAB)) (-RRB- -RRB-))) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ-1 (NP (DT the) (NML (NML (JJ middle) (NN ear) (NN cavity)) (-LRB- -LRB-) (NML (NN MEC))) (-RRB- -RRB-)) (PP (IN of) (NP (JJ mutant) (NNS mice)))) (VP (VBD was) (VP (VBN filled) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN exudate))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ indicative) (PP (IN of) (NP (NN OM)))))))))) (. .)) )
( (S (NP-SBJ (NN X-ray) (NN analysis)) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (NP (DT no) (JJ consistent) (NN abnormality)) (PP (IN of) (NP (NNS bullae) (NN shape)))) (ADJP (VBN associated) (PP (IN with) (NP (NN OM))))) (PP-LOC (IN in) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))))))) (. .)) )
( (S (NP-SBJ (NP (NN Examination)) (PP (IN of) (NP (CD seven) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))) (PRN (-LRB- -LRB-) (NP (CD 14) (NNS bullae)) (, ,) (NP (QP (SYM >) (CD 180)) (NN DAB)) (-RRB- -RRB-))) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (CD 6) (NML (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)) (NNS bullae)) (VP (VP (VBD had) (NP (DT a) (JJ normal) (NN shape))) (CC and) (VP (VBD demonstrated) (NP (NN radio) (NN opacity)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG indicating) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NP (DT an) (NN effusion)) (PP-LOC (IN in) (NP (DT the) (JJ middle) (NN ear)))))))) (, ,) (SBAR-ADV (IN whereas) (S (PP-LOC (IN in) (NP (CD six) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))) (, ,) (NP-SBJ (NNS bullae)) (VP (VP (VBD were) (ADJP-PRD (JJ misshapen))) (CC and) (ADVP (RB also)) (VP (VBD had) (S (NP-SBJ (DT an) (NN effusion)) (ADJP-PRD (JJ present))) (-LRB- -LRB-) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN demonstrated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NN radio) (NN opacity)))))))))))))) (-RRB- -RRB-) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ (NN X-ray) (NN imaging)) (VP (VBZ is) (NP-PRD (NP (DT a) (ADJP (RBR less) (JJ sensitive)) (NNS means)) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG diagnosing) (NP (NN OM))))) (PP (IN than) (NP (NN histology))))))) (, ,) (NP-SBJ (CD two) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice) (NNS bullae)) (VP (VBD did) (RB not) (VP (VB demonstrate) (NP (DT a) (NN radio) (NN opacity)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG reflecting) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (NP (NN resolution)) (PP (IN of) (NP (NP (DT a) (JJ small) (NN number)) (PP (IN of) (NP (NP (NN Junbo) (NNS mice)) (PP-TMP (IN at) (NP (VBN advanced) (NN age)))))))))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (ADVP (RB below)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NN Control) (NNS ears) (PRN (-LRB- -LRB-) (NP (CD two) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)) (, ,) (NP (CD four) (NNS bullae)) (-RRB- -RRB-))) (VP (VP (VBD were) (ADJP-PRD (JJ clear) (PP (IN of) (NP (NN effusion))))) (CC and) (VP (VBD presented) (PP (IN with) (NP (DT a) (JJ normal) (NNS bullae) (NN shape))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD concluded) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN presence)) (PP (IN of) (NP (ADJP (RB abnormally) (VBN shaped)) (NNS bullae))) (PP-LOC (IN in) (NP (DT the) (NN Junbo) (NN mutant)))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ necessary) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT an) (NN effusion)))))))))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (ADVP (RB therefore)) (VP (VBD proceeded) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB study) (NP (NP (DT the) (NN pathology)) (PP (IN of) (NP (DT the) (NN OM)))) (PP-TMP (PP (IN in) (NP (DT the) (JJ postnatal) (NN period))) (, ,) (PP (IN at) (NP (VBG weaning))) (, ,) (CC and) (PP (IN in) (NP (DT the) (NN adult)))) (, ,) (PP-LOC (PP (ADVP-TMP (RB first)) (IN in) (NP (NP (ADJP (RB conventionally) (VBN housed)) (NNS mice)) (PP (IN of) (NP (ADJP (RB relatively) (JJ low)) (JJ microbiological) (NN status))))) (CC and) (PP (ADVP-TMP (RB then)) (IN in) (NP (ADJP (NP (JJ specific) (NN pathogen)) (HYPH -) (JJ free) (PRN (-LRB- -LRB-) (ADJP (JJ SPF)) (-RRB- -RRB-))) (NNS mice)))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (ADJP (RB conventionally) (VBN housed)) (NNS mice))) (NP-SBJ (PRP we)) (VP (VBD found) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (NP (NN inflammation)) (PP (IN of) (NP (DT the) (JJ embryonic) (JJ connective) (NN tissue)))) (CC or) (NP (NP (NN exudation)) (PP (IN into) (NP (DT the) (NN MEC))))))) (PP-LOC (IN in) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC or) (NML (JJ wild) (HYPH -) (NN type))) (NN litter) (NNS mates))) (PP-TMP (IN at) (NP (CD 5) (NNS DAB)))) (. .)) )
( (S (S (PP-TMP (IN By) (NP (CD 13) (NNS DAB))) (NP-SBJ-1 (DT the) (NN MEC)) (VP (VBZ is) (ADVP (RBR more) (RB fully)) (VP (VBN formed) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ (NP (NP (CD 100) (NN %)) (PP (IN of) (NP (DT the) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)))) (CC and) (NP (NML (QP (SYM ~) (CD 33)) (NN %)) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))) (VP (VBD had) (NP (JJ acute) (NN OM)) (PRN (-LRB- -LRB-) (NP (NP (NN Figure) (NN 2A)) (PP (SYM –) (NP (NN 2D)))) (-RRB- -RRB-)))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)) (VP (VBD had) (NP (JJ suppurative) (NN exudate)) (PP-LOC (IN in) (NP (PDT both) (DT the) (NNS MECs))) (, ,) (SBAR-ADV (IN while) (S (NP-SBJ (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)) (VP (VP (VBD had) (NP=2 (NP (JJ unilateral) (NN OM)) (, ,) (CC or) (NP (JJ serous) (NN exudation))) (PP-LOC=1 (IN in) (NP (CD one) (NN ear)))) (CC and) (VP (NP=2 (JJ suppurative) (NN exudation)) (PP-LOC=1 (IN in) (NP (DT the) (JJ contralateral) (NN ear)))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Typical) (JJ acute) (JJ inflammatory) (NNS changes)) (PP-LOC (IN in) (NP (DT the) (NN MEC) (NN mucoperiosteum)))) (VP (VBD included) (NP (NP (JJ edematous) (NNS polyps) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2E)) (, ,))) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD may) (VP (VB represent) (NP (NP (JJ unresorbed) (JJ embryonic) (JJ connective) (NN tissue) (PRN (-LRB- [) (NP (CD 17)) (-RRB- ]))) (-RRB- -RRB-) (CONJP (CC and) (HYPH /) (CC or)) (NP (NP (VBG bulging) (JJ sub-epithelial) (NNS bullae)) (VP (VBN filled) (NP (-NONE- *)) (PP-MNR (IN with) (NP (NP (JJ serous) (NN fluid)) (, ,) (NP (JJ stromal) (NN edema)) (, ,) (NP (ADJP (RB widely) (JJ patent)) (NNS capillaries)) (, ,) (CC and) (NP (NNS lymphatics)))) (, ,) (PP (IN with) (NP (NP (JJ variable) (NNS numbers)) (PP (IN of) (NP (VBG infiltrating) (NN neutrophil) (NNS leukocytes)))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (JJ epithelial) (NN covering)) (VP (VBD was) (VP (VBN formed) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (JJ small) (JJ basal) (NNS cells)) (CC or) (NP (VBN ciliated) (JJ columnar) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 2F) (CC and) (NN 2G))) (-RRB- -RRB-)))) (. .)) )
( (S (S (NP-SBJ (NP (NP (DT A) (JJ second) (, ,) (JJR milder) (NN type)) (PP (IN of) (NP (NN OM)))) (VP-1 (-NONE- *ICH*))) (VP (VBD occurred) (PP (IN in) (NP (NP (DT a) (JJ further) (QP (SYM ~) (CD 27)) (NN %)) (PP (IN of) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))))) (VP-1 (VBG consisting) (PP (IN of) (NP (NP (JJ only) (JJ focal) (JJ mucoperiosteal) (NNS aggregations)) (PP (IN of) (NP (NN neutrophil) (NNS leucocytes))) (PP (IN with) (CC or) (IN without) (NP (DT a) (JJ light) (NN neutrophil) (NN leukocyte) (NN MEC) (NN exudation))))) (CIT (-LRB- -LRB-) (JJ unpublished) (NNS data) (-RRB- -RRB-))))) (: ;) (S (NP-SBJ (NML (QP (SYM ~) (CD 40)) (NN %)) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)) (VP (VBD had) (NP (NP (DT no) (NN evidence)) (PP (IN of) (NP (NN OM)))) (PP-TMP (IN at) (NP (DT this) (NN age))))) (. .)) )
( (S (ADVP (RB Importantly)) (, ,) (NP-SBJ (NN OM)) (VP (VBD appeared) (PP-TMP (IN at) (NP (DT this) (NN stage))) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT a) (ADJP (RBR more) (VBN generalized)) (NML (JJ respiratory) (NN tract)) (NN inflammation)) (VP (VBG comprising) (NP (NP (JJ suppurative) (NN rhinitis) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2H)) (-RRB- -RRB-))) (CC and) (NP (NN nasopharyngitis)) (, ,) (CC and) (NP (NP (JJ multifocal) (NML (NML (JJ mild) (NN alveolitis)) (HYPH /) (NML (JJ interstitial) (NN pneumonia)))) (PP (PP (IN with) (NP (NP (NN eosinophil) (NNS leukocytes)) (PP-LOC (IN in) (NP (JJ perivascular) (NNS cuffs))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 3A) (CC and) (NN 3B))) (-RRB- -RRB-)))) (CC but) (PP (IN without) (NP (NP (NN evidence)) (PP (IN of) (NP (NP (JJ intralesional) (NNS bacteria)) (CC or) (NP (JJ viral) (NNS inclusions))))))))))))))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBD were) (NP-PRD (DT no) (JJ significant) (JJ histological) (NNS lesions)) (PP-LOC (IN in) (NP (NN intestine) (, ,) (NN liver) (, ,) (NN pancreas) (, ,) (NN kidney) (, ,) (NN heart) (, ,) (NN thymus) (, ,) (CC and) (NN spleen)))) (. .)) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (HEADING (NP (NP (NN Histology)) (PP (IN of) (NP (NP (JJ Middle) (NN Ear)) (CC and) (NP (NN Nose)))) (PP-LOC (IN in) (NP (NML (NML (JJ Wild) (HYPH -) (NN Type)) (CC and) (NML (NN Junbo))) (JJ Mutant) (NNS Mice))))) )
( (CAPTION (S (NP-SBJ-1 (NNS Images) (PRN (-LRB- -LRB-) (NP (NP (NN a)) (PP (SYM –) (NP (NN h)))) (-RRB- -RRB-))) (VP (VP (VBP are) (PP-PRD (IN from) (NP (ADJP (NP (CD 13) (HYPH -) (NN d)) (HYPH -) (JJ old)) (JJ postnatal) (NNS mice)))) (CC and) (VP (VBP are) (VP (VBN given) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NP (PRP$ their) (NML (JJ original) (NN magnification) (PRN (-LRB- -LRB-) (NP (DT a)) (-RRB- -RRB-))) (NML (NN Jbo) (HYPH /) (SYM +)) (JJ dorsal) (NN section)) (PP (IN of) (NP (NP (NN MEC)) (VP (ADVP (RB partly)) (VBN filled) (NP (-NONE- *)) (PP (IN with) (NP (NN exudate)))))) (NP-ADV (SYM ×) (CD 40))) (, ,) (NP (PRN (-LRB- -LRB-) (NP (NN b)) (-RRB- -RRB-)) (NP (NP (NML (SYM +) (HYPH /) (SYM +)) (JJ normal) (NML (JJ middle) (NN ear)) (JJ temporal) (NN bone)) (VP (VBN covered) (NP (-NONE- *)) (PP (IN with) (NP (JJ thin) (NN mucoperiosteum))) (PRN (-LRB- -LRB-) (NP (NNS arrowheads)) (-RRB- -RRB-)))) (NP-ADV (SYM ×) (CD 400))) (, ,) (NP (PRN (-LRB- -LRB-) (NP (NN c)) (-RRB- -RRB-)) (NP (NML (SYM +) (HYPH /) (SYM +)) (JJ inflamed) (JJ middle) (NN ear)) (PP (IN with) (NP (NP (VBN thickened) (NN mucoperiosteum)) (PP (IN with) (NP (NP (NML (NN neutrophil) (NN leukocyte)) (NNS infiltrates)) (CC and) (NP (ADJP (NN neutrophil) (HYPH -) (JJ rich)) (NNS exudates)))) (PP-LOC (IN in) (NP (DT the) (NN MEC))))) (NP-ADV (SYM ×) (CD 400))) (, ,) (NP (PRN (-LRB- -LRB-) (NP (NN d)) (-RRB- -RRB-)) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (JJ middle) (NN ear)) (PP (IN with) (NP (NP (ADJP (RBR more) (JJ severe)) (JJ suppurative) (NN exudation)) (PP (IN into) (NP (DT the) (NN MEC))))) (NP-ADV (SYM ×) (CD 400))) (, ,) (NP (PRN (-LRB- -LRB-) (NP (NN e)) (-RRB- -RRB-)) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (JJ inflamed) (JJ edematous) (NN polyp) (PRN (-LRB- -LRB-) (NP (NN arrowhead)) (-RRB- -RRB-))) (PP (IN of) (NP (NP (JJ un-resorbed) (JJ embryonic) (NML (JJ middle) (NN ear)) (JJ connective) (NN tissue)) (, ,) (NP (JJ tympanic) (NN membrane)))) (NP-ADV (SYM ×) (CD 100))) (, ,) (NP (PRN (-LRB- -LRB-) (NP (NN f)) (-RRB- -RRB-)) (NP (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NN MEC)) (VP (VBN lined) (NP (-NONE- *)) (PP (IN by) (NP-LGS (VBN ciliated) (JJ columnar) (NNS cells))) (PRN (-LRB- -LRB-) (NP (NN arrowhead)) (-RRB- -RRB-)))) (NP-ADV (SYM ×) (CD 600))) (NP (PRN (-LRB- -LRB-) (NP (NN g)) (-RRB- -RRB-)) (NP (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NN MEC)) (VP (VBN lined) (NP (-NONE- *)) (PP (IN by) (NP-LGS (JJ basal) (NNS cells))) (PRN (-LRB- -LRB-) (NP (NN arrowhead)) (-RRB- -RRB-)))) (NP-ADV (SYM ×) (NN 600))) (, ,) (NP (PRN (-LRB- -LRB-) (NP (NN h)) (-RRB- -RRB-)) (NP (NP (NML (NN Jbo) (HYPH /) (SYM +)) (JJ suppurative) (NN rhinitis)) (: :) (NP (NP (NP (JJ nasal) (NN cavity)) (PP (IN with) (NP (JJ suppurative) (NN exudate)))) (, ,) (NP (NP (JJ nasal) (NN septum)) (PP (IN with) (NP (JJ inflamed) (JJ nasal) (NN mucosa)))))) (NP-ADV (SYM ×) (CD 200)))))))) (. .))) )
( (CAPTION (S (S (NP-SBJ (NNS Images) (PRN (-LRB- -LRB-) (NP (NP (NN i)) (PP (SYM –) (NP (NN l)))) (-RRB- -RRB-))) (VP (VBP are) (PP-PRD (IN of) (NP (NP (ADJP (JJ adult) (PRN (-LRB- -LRB-) (NP (CD 180) (HYPH -) (NNS d)) (-RRB- -RRB-))) (NML (NN Jbo) (HYPH /) (SYM +)) (JJ middle) (NN ear)) (PP (IN with) (NP (JJ chronic) (JJ suppurative) (NN OM))))))) (: ;) (S (NP-SBJ (NNS changes)) (VP (VBP include) (NP (NP (NP (LST (-LRB- -LRB-) (LS i) (-RRB- -RRB-)) (JJ fibrous) (NNS polyps) (PRN (-LRB- -LRB-) (NP (NNS arrowheads)) (-RRB- -RRB-))) (NP-ADV (SYM ×) (CD 200))) (, ,) (NP (LST (-LRB- -LRB-) (LS j) (-RRB- -RRB-)) (NP (NP (NP (NN hyperplasia)) (PP (IN of) (NP (VBN ciliated) (JJ epithelial) (NNS cells) (PRN (-LRB- -LRB-) (NP (NN arrowhead)) (-RRB- -RRB-))))) (CC and) (NP (NP (NN fibrosis)) (PP (IN of) (NP (NN mucoperiosteum) (NN stroma))))) (NP-ADV (SYM ×) (CD 400))) (, ,) (CC and) (NP (LST (-LRB- -LRB-) (LS k) (-RRB- -RRB-)) (NP (JJ fibrous) (NN thickening)) (PP (IN of) (NP (NP (DT the) (JJ tympanic) (NN membrane)) (, ,) (NP (JJ outer) (NN ear) (NN canal)))) (NP-ADV (SYM ×) (CD 400)) (PP (VBN compared) (PP (IN with) (NP (NP (LST (-LRB- -LRB-) (LS l) (-RRB- -RRB-)) (JJ normal) (NML (SYM +) (HYPH /) (SYM +)) (JJ tympanic) (NN membrane)) (, ,) (NP-ADV (JJ outer) (NN ear) (NN canal)) (NP-ADV (SYM ×) (CD 400))))))))) (. .))) )
( (CAPTION (NP (NP (NP (NN E)) (, ,) (NP (NN exudate))) (: ;) (NP (NP (NN MP)) (, ,) (NP (NN mucoperiosteum))) (: ;) (NP (NP (NN NC)) (, ,) (NP (JJ nasal) (NN cavity))) (: ;) (NP (NP (NN NM)) (, ,) (NP (JJ nasal) (NN mucosa))) (: ;) (NP (NP (NN NS)) (, ,) (NP (JJ nasal) (NN septum))) (: ;) (NP (NP (NN OEC)) (, ,) (NP (JJ outer) (NN ear) (NN canal))) (: ;) (NP (NP (NN TB)) (, ,) (NP (JJ temporal) (NN bone))) (: ;) (NP (NP (NN TM)) (, ,) (NP (JJ tympanic) (NN membrane))))) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (HEADING (NP (NP (NN Histology)) (PP (IN of) (NP (DT the) (NML (NML (NN Lung)) (CC and) (NML (JJ Middle) (NN Ear))) (NN Exudate))) (PP-LOC (IN in) (NP (NN Junbo) (NNS Mice))))) )
( (CAPTION (NP (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (ADJP (NP (CD 13) (HYPH -) (NN d)) (JJ postnatal)) (NML (NN Jbo) (HYPH /) (SYM +)) (NN lung)) (PP (IN with) (NP (NP (ADJP (JJ perivascular) (CC and) (JJ peribronchiolar)) (NNS cuffs)) (VP (VBG containing) (NP (NP (NP (NML (NNP Sirius) (VBD red)) (JJ positive) (NN eosinophil) (NNS leukocytes) (PRN (-LRB- -LRB-) (NP (NN arrowhead)) (-RRB- -RRB-))) (, ,) (NP (NN bronchiole)) (, ,) (NP (JJ pulmonary) (NN artery))) (NP (SYM ×) (CD 400))))))) (, ,) (NP (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP (NP (JJ focal) (JJ eosiniphilic) (NN alveolitis) (PRN (-LRB- -LRB-) (NP (NN arrowhead)) (-RRB- -RRB-))) (CC and) (NP (VBN thickened) (JJ alveolar) (NNS septae) (PRN (-LRB- -LRB-) (NP (JJ open) (NN arrowhead)) (-RRB- -RRB-)))) (PP (IN with) (NP (ADJP (NN eosinophil) (HYPH -) (JJ rich)) (NNS infiltrates)))) (. .))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (NP (NP (ADJP (NP (CD 21) (HYPH -) (NN d)) (JJ postnatal)) (NML (NN Jbo) (HYPH /) (SYM +)) (NN MEC) (NN pus)) (PP (IN with) (NP (NP (NNS colonies)) (PP (IN of) (NP (ADJP (NN Gram) (JJ positive)) (NNS cocci)))))) (NP-ADV (SYM ×) (CD 600)) (. .))) )
( (CAPTION (NP (NP (NP (NN B)) (, ,) (NP (NN bronchiole))) (: ;) (NP (NP (NN PA)) (, ,) (NP (JJ pulmonary) (NN artery))))) )
( (S (S (NP-SBJ (DT Any) (JJ postnatal) (NN OM)) (VP (VBD had) (VP (VBN resolved) (PP-LOC (IN in) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))) (PP-MNR (IN by) (NP (VBG weaning))) (PRN (-LRB- -LRB-) (NP (NP (NML (CD 0) (NN %)) (NN incidence)) (PP-TMP (IN at) (NP (CD 21) (NNS DAB)))) (-RRB- -RRB-))))) (CC and) (S (NP-SBJ (NN OM)) (VP (VBD was) (ADJP-PRD (JJ exceptional)) (PP-LOC (IN in) (NP (NNS adults))) (PRN (-LRB- -LRB-) (NP (NML (CD 3) (NN %)) (NN incidence)) (-RRB- -RRB-)))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NN OM)) (VP (VP (VBD was) (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (NP (CD 100) (NN %)) (PP (IN of) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))))) (PP-TMP (IN at) (NP (VBG weaning)))) (CC and) (VP (VBD occurred) (PP-LOC (IN in) (NP (NP (CD 94) (NN %)) (PP (IN of) (NP (JJ adult) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))))) (NP-TMP (NP (CD 29) (NNS DAB)) (PP (IN to) (NP (QP (SYM >) (CD 180)) (NNS DAB)))))) (. .)) )
( (S (S (NP-SBJ (JJ Suppurative) (NN rhinitis)) (VP (VBD was) (ADVP-TMP (RB still)) (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (NP (DT some) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)) (VP (VBN examined) (NP (-NONE- *))))))) (, ,) (CC but) (S (PP-LOC (IN in) (NP (CD two))) (NP-SBJ (DT the) (JJ eosinophilic) (NN pneumonia)) (VP (VBD was) (ADJP-PRD (JJ absent) (CC or) (JJ minimal)))) (. .)) )
( (S (NP-SBJ (NP (JJ Large) (NNS numbers)) (PP (IN of) (NP (ADJP (NN Gram) (JJ positive)) (NNS cocci)))) (VP (VBD were) (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (NN OM) (NN exudate))) (PP-TMP (IN at) (NP (NN day) (CD 21))) (PP-LOC (IN in) (NP (NP (QP (SYM ~) (CD 70)) (NN %)) (PP (IN of) (NP (NNS cases))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 3C)) (-RRB- -RRB-)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (SBAR (-NONE- *0*) (S (NP-SBJ (NP (JJ nasopharyngeal) (JJ staphylococcal)) (CC and) (NP (JJ streptococcal) (NN flora))) (VP (MD may) (VP (VB play) (NP (DT a) (NN role)) (PP (IN in) (NP (NP (NN progression)) (PP (IN of) (NP (NN OM))))) (, ,) (SBAR-ADV (IN if) (RB not) (FRAG (NP (NP (PRP$ its) (NN initiation)) (PP-LOC (IN in) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))))))))))))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBD was) (NP-PRD (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (JJ significant) (NN proliferation)) (PP (IN of) (NP (NP (JJ mucous) (NNS cells)) (CC or) (NP (NML (JJ periodic) (NN acid)) (HYPH -) (ADJP (NNP Schiff) (HYPH -) (JJ positive)) (NN mucus)))) (PP-LOC (IN in) (NP (DT the) (NN MEC))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Adult) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)) (ADJP (SYM >) (NP (CD 29) (NNS DAB)))) (VP (VBP develop) (NP (JJ bilateral) (JJ chronic) (JJ suppurative) (NN OM))) (. .)) )
( (S (S (NP-SBJ (JJ Chronic) (NML (JJ middle) (NN ear)) (NNS effusions)) (VP (VBD contained) (NP (NP (JJ variable) (NML (NNS numbers) (CC and) (NNS proportions))) (PP (IN of) (NP (NP (ADJP (JJ viable) (CC and) (JJ necrotic)) (NN neutrophil) (NNS leukocytes)) (CC and) (NP (JJ foamy) (NNS macrophages))))))) (: ;) (S (NP-SBJ (NNS bacteria)) (VP (VBD were) (ADVP-TMP (RB infrequently)) (ADJP-PRD (JJ present)))) (CC and) (S (NP-SBJ (EX there)) (VP (VBD were) (NP-PRD (NP (NP (JJ small) (NNS numbers)) (PP (IN of) (NP (JJ multinucleate) (NNS macrophages)))) (, ,) (NP (NN cholesterol) (NNS clefts)) (, ,) (CC and) (NP (NP (JJ small) (NNS amounts)) (PP (IN of) (NP (NP (JJ birefringent) (JJ foreign) (NN body)) (-LRB- -LRB-) (ADJP (RB perhaps) (JJ secondary) (PP (IN to) (NP (NP (NN perforation)) (PP (IN of) (NP (DT the) (NN eardrum)))))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ (DT The) (NNS effusions)) (VP (VBD did) (RB not) (VP (VB contain) (NP (NP (JJ significant) (NNS amounts)) (PP (IN of) (NP (NML (JJ periodic) (NN acid)) (HYPH -) (ADJP (NNP Schiff) (HYPH -) (JJ positive)) (NN mucus)))))) (. .)) )
( (S (NP-SBJ (NP (JJ Chronic) (NNS changes)) (PP (IN in) (NP (JJ inflamed) (VBN thickened) (NN mucoperiosteum)))) (VP (VBP include) (NP (NP (NN formation)) (PP (IN of) (NP (NP (JJ multiple) (NNS polyps) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2I)) (-RRB- -RRB-))) (VP (VBN covered) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (JJ low) (JJ cuboidal) (NNS cells)) (CC or) (NP (JJ hyperplastic) (VBN ciliated) (JJ columnar) (NNS cells))) (CC and) (NP (VBN scattered) (JJ mucous) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2J)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ mucoperiosteal) (NN stroma)) (VP (VBZ has) (NP (NP (JJ variable) (NNS degrees)) (PP (IN of) (NP (NP (NN fibrosis)) (, ,) (NP (NN neutrophil) (NN leukocyte) (NN infiltration)) (, ,) (NP (JJ scattered) (NN mast) (NNS cells)) (, ,) (NP (JJ lymphoplasmacytic) (NNS infiltrates)) (, ,) (CC and) (NP (JJ occasional) (JJ lymphoid) (NNS nodules)))))) (. .)) )
( (S (S (NP-SBJ (DT The) (JJ eustachian) (NN tube)) (VP (VP (VBZ is) (ADJP-PRD (JJ patent))) (CC and) (VP (MD can) (VP (VB contain) (NP (NNS exudates)))))) (, ,) (CC and) (S (NP-SBJ (DT the) (JJ epithelial) (NN lining)) (VP (MD can) (VP (VB have) (NP (NP (VBN elevated) (NNS numbers)) (PP (IN of) (NP (NP (JJ mucous) (NNS cells)) (CC and) (NP (JJ intra-epithelial) (NNS leukocytes)))))))) (. .)) )
( (S (NP-SBJ (NP (NP (JJ Fibrous) (NN thickening)) (PP (IN of) (NP (DT the) (NN eardrum)))) (-LRB- -LRB-) (NP (NN tympanosclerosis))) (-RRB- -RRB-) (VP (VBZ is) (ADJP-PRD (JJ common)) (PRN (-LRB- -LRB-) (NP (NN Figure) (NML (NN 2K) (CC and) (NN 2L))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NN OM)) (VP (VBD was) (ADVP-TMP (RB often)) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NP (NN perforation)) (PP (IN of) (NP (DT the) (NN eardrum)))) (, ,) (VP (ADVP (RB possibly)) (VBG providing) (NP (NN drainage))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB account) (PP (IN for) (NP (NP (JJ apparent) (NN resolution)) (PP (IN of) (NP (NP (DT a) (JJ few) (NNS cases)) (: :) (-LRB- -LRB-) (NP (NP (CD 6) (NN %)) (-RRB- -RRB-) (PP (IN of) (NP (NN OM))) (PP-LOC (IN in) (NP (NP (DT the) (JJS oldest) (NN age) (NN group)) (PP (IN of) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))) (PRN (-LRB- -LRB-) (NP (QP (SYM >) (CD 180)) (NNS DAB)) (-RRB- -RRB-)))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN Junbo) (NN colony)) (VP (VBZ has) (ADVP-TMP (RB subsequently)) (VP (VBN been) (VP (VBN re-derived) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN embryo) (NN transfer))) (PP (IN into) (NP (NP (NP (JJ new) (NML (JJ high) (HYPH -) (NN health) (NN status)) (NNS facilities)) (-LRB- -LRB-) (NP (NNP Mary) (NNP Lyon) (NNP Centre))) (, ,) (NP-LOC (NNP Harwell))))))) (-RRB- -RRB-) (. .)) )
( (S (S (NP-SBJ-1 (NNS Mice)) (VP (VBP are) (VP (VBN housed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (RB individually) (VBN ventilated)) (NNS cages)))))) (, ,) (CC and) (S (NP-SBJ (NN screening)) (VP (VBZ shows) (SBAR (-NONE- *0*) (S (NP-SBJ-2 (DT all) (ADJP (NNP FELASA) (HYPH -) (VBN listed)) (NNS pathogens) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Materials) (CC and) (NNS Methods)))) (-RRB- -RRB-))) (VP (VBP have) (VP (VBN been) (VP (VBN excluded) (NP-2 (-NONE- *))))))))) (: ;) (S (NP-SBJ (NP (CD 75) (NML (NN cage) (NN air)) (NNS changes)) (PP (SYM /) (NP (NN h)))) (VP (VBP reduce) (NP (NP (JJ respiratory) (NNS irritants)) (PP (JJ such) (IN as) (NP (NN ammonia)))) (PP (IN to) (NP (QP (SYM <) (CD 3)) (NNS ppm))))) (. .)) )
( (S (PP (IN In) (NP (JJ SPF) (NNS conditions))) (, ,) (NP-SBJ-1 (NP (NN OM)) (PP-LOC (IN in) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)))) (VP (VP (VBZ is) (ADJP-PRD (RB relatively) (JJR milder)) (PP-TMP (IN at) (NP (JJ early) (NN time) (NNS points)))) (CC and) (VP (VBZ is) (RB not) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NN rhinitis)))))) (. .)) )
( (S (ADVP (RB Typically)) (PP-TMP (IN at) (NP (CD 13) (NNS DAB))) (NP-SBJ (EX there)) (VP (VBP are) (NP-PRD (NP (NP (JJ small) (NNS numbers)) (PP (IN of) (NP (NP (JJ inflammatory) (NNS cells)) (PP-LOC (IN in) (NP (DT the) (NN mucoperiosteum)))))) (CC and) (NP (ADVP (RB sometimes)) (, ,) (JJ light) (NN MEC) (NN effusion)))) (. .)) )
( (S (PP-TMP (IN By) (NP (NP (QP (CD 20) (SYM –) (CD 22)) (NNS DAB)) (CC and) (NP (CD 28) (NNS DAB)))) (, ,) (S (S (NP-SBJ (NML=1 (CD 4) (NN %)) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)) (VP (VBD had) (NP=2 (JJ bilateral) (NN OM)))) (, ,) (S (NML=1 (CD 54) (NN %)) (NP=2 (JJ unilateral) (NN OM))) (, ,) (CC and) (S (NML=1 (CD 42) (NN %)) (VP (VBD had) (NP=2 (NP (ADJP (RB very) (JJ mild)) (NML-3 (-NONE- *RNR*))) (CC or) (NP (DT no) (NML-3 (-NONE- *RNR*))) (NML-3 (NN OM)))))) (. .)) )
( (S (S (ADVP (RB However)) (, ,) (PP-TMP (IN by) (NP (CD 54) (NNS DAB))) (, ,) (NP-SBJ (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice) (PRN (-LRB- -LRB-) (NP (CD 100) (NN %)) (-RRB- -RRB-))) (VP (VBD had) (NP (NN OM)))) (, ,) (CC but) (S (PP-LOC (IN in) (NP (NP (CD 10) (NN %)) (PP (IN of) (NP (NNS cases))))) (NP-SBJ (DT this)) (VP (VBD was) (ADJP-PRD (JJ unilateral)))) (. .)) )
( (S (NP-SBJ (NN OM)) (VP (VBZ does) (RB not) (VP (VB occur) (PP-LOC (PP (IN in) (NP (VBN pre-weaned) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))) (CC and) (PP (IN in) (NP (NP (NP (QP (RB only) (CD 3)) (NN %)) (-LRB- -LRB-) (NP (NP (DT a) (JJ single) (NN case)) (PP-LOC (IN in) (NP (DT a) (NML (CD 22) (HYPH -) (NNS DAB)) (NN mouse))))) (-RRB- -RRB-) (PP (IN of) (NP (JJR older) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Comprehensive) (NN pathology) (NN phenotyping)) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB show) (NP (NP (DT a) (JJ consistent) (NN pattern)) (PP (IN of) (NP (JJ significant) (NN organ) (NN pathology)))) (PP (IN outside) (PP (IN of) (NP (DT the) (JJ middle) (NN ear)))) (PP-LOC (IN in) (NP (JJ adult) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))))))) (. .)) )
( (S (ADVP (RB Specifically)) (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT no) (NN evidence)) (PP (IN of) (NP (NP (NP (JJ opportunistic) (NNS infections)) (PP-LOC (IN in) (NP (NP (NNS sites)) (PP (JJ such) (IN as) (NP (NP (NN skin)) (, ,) (NP (NN lung)) (, ,) (NP (NN urogenital)) (, ,) (CC or) (NP (NN gastrointestinal) (NNS systems))))))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD might) (VP (VB be) (NP-PRD (NP (DT a) (NN sign)) (PP (IN of) (NP (NN immune) (NN deficiency))))))))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (ADVP (RB below)))) (-RRB- -RRB-))) (. .)) )
( (S (S (PP (IN In) (NP (NN summary))) (, ,) (NP-SBJ (NP (NP (DT the) (JJ microbiological) (NN status)) (PP (IN of) (NP (DT the) (NNS mice)))) (CONJP (CC and) (HYPH /) (CC or)) (NP (NN air) (NN quality))) (VP (VBP affect) (NP (NP (NN onset)) (PP (IN of) (NP (NN OM)))))) (, ,) (CC and) (S (PP (IN under) (`` “) (NP (JJ dirty) ('' ”) (JJ conventional) (NNS conditions))) (NP-SBJ (RB even) (NML (JJ wild) (HYPH -) (NN type)) (NNS mice)) (VP (MD can) (VP (VB develop) (NP (NN OM)) (PP-TMP (IN in) (NP (DT the) (JJ postnatal) (NN period))) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NML (JJ upper) (JJ respiratory) (NN tract)) (NN disease)))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP-SBJ (DT this)) (VP (VBZ resolves) (PP-LOC (IN in) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))) (PP-TMP (IN by) (NP (VBG weaning))))) (. .)) )
( (S (PP-LOC (IN In) (NP (ADJP (ADJP (RB conventionally) (VBN housed)) (CC and) (ADJP (JJ SPF))) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))) (, ,) (NP-SBJ (NN OM)) (VP (VBZ emerges) (PP (IN as) (NP (DT a) (JJ chronic) (NN condition)))) (. .)) )
( (HEADING (NP (NP (NP (NN Immunology)) (CC and) (NP (NN FACS) (NN Analysis))) (PP (IN of) (NP (JJ SPF) (NML (NML (JJ Wild) (HYPH -) (NN Type)) (CC and) (NML (NN Junbo))) (NNS Mice))))) )
( (S (NP-SBJ (EX There)) (VP (VBD were) (NP-PRD (NP (DT no) (JJ significant) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN antibody) (NNS responses)) (PP (IN of) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (JJ wild) (HYPH -) (NN type))) (NN control) (NNS mice))) (PP (IN to) (NP (NP (NN immunization)) (PP (IN with) (NP (ADJP (ADJP (NN T) (HYPH -) (JJ dependent) (PRN (-LRB- -LRB-) (NP (NP (NN IgG1) (CC and) (NN IgG2a)) (PP (IN to) (NP (NN keyhole) (NN limpet) (NN hemocyanin)))) (-RRB- -RRB-))) (CC and) (ADJP (NN T) (HYPH -) (JJ independent) (PRN (-LRB- -LRB-) (NP (NP (NN IgGM) (CC and) (NN IgG3)) (PP (IN to) (NP (NN pneumococcal) (NN polysaccharide) (NN type) (CD 3)))) (-RRB- -RRB-)))) (NNS antigens)))))))) (PRN (-LRB- -LRB-) (NP (NN Table) (NN S1)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (NN FACS) (NN analysis)) (PP (IN of) (NP (NP (NN blood) (NNS neutrophils)) (VP (VBN identified) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NN cell) (NN surface) (NNS markers)) (NP (NP (NN Gr) (HYPH -) (CD 1)) (CC and) (NP (NN Mac) (HYPH -) (CD 1))))))))) (VP (VBD did) (RB not) (VP (VB reveal) (NP (NP (JJ significant) (NNS differences)) (PP (IN between) (NP (NP (NNS levels)) (PP (IN of) (NP (NP (NP (JJ immature) (NML-1 (-NONE- *RNR*))) (, ,) (NP (JJ mature) (NML-1 (-NONE- *RNR*))) (NML-1 (NN cell) (NNS forms))) (, ,) (CC and) (NP (JJ total) (VBG circulating) (NN blood) (NNS neutrophils))))))) (PP-LOC (IN in) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (JJ wild) (HYPH -) (NN type))) (NNS mice))) (PP-TMP (IN at) (NP (CC either) (NP (QP (CD 20) (SYM –) (CD 22)) (NNS DAB)) (CC or) (NP (QP (CD 49) (SYM –) (CD 58)) (NNS DAB)))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (DT a) (ADJP (RB significantly) (JJR lower) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN p)) (VP (SYM =) (NP (CD 0.003)))) (-RRB- -RRB-))) (NN ratio)) (PP (IN of) (NP (JJ immature) (NNS forms)))) (PP-LOC (IN in) (NP (DT the) (VBG circulating) (NN neutrophil) (NN pool))) (PP-LOC (PP (IN in) (NP (NML (QP (CD 20) (SYM –) (CD 22)) (NNS DAB)) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))) (, ,) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NML (QP (CD 54) (HYPH –) (CD 58)) (NNS DAB)) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))) (. .)) )
( (HEADING (NP (NN Table) (CD 1))) )
( (HEADING (NP (NP (NN FACS) (NN Analysis)) (PP (IN of) (NP (NP (DT the) (NN Proportion)) (PP (IN of) (NP (NNS Granulocytes))) (PP-LOC (IN in) (NP (NP (NN Blood)) (PP (IN of) (NP (NML (NML (NN Wild) (HYPH -) (NN Type)) (CC and) (NML (NN Junbo))) (NNS Mice))))))))) )
( (HEADING (NP (NP (NN Expression)) (PP (IN of) (NP (NN Evi1))) (PP-LOC (IN in) (NP (NML (NML (JJ Wild) (HYPH -) (NN Type)) (CC and) (NML (NN Junbo))) (NNS Mice))))) )
( (S (NP-SBJ-1 (PRP We)) (VP (VBD proceeded) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (NN Evi1))) (PP-LOC (IN in) (NP (CC both) (NP (JJ embryonic) (NML (JJ whole) (HYPH -) (NN body)) (NNS tissues) (PRN (-LRB- -LRB-) (NP-TMP (NN E9.5)) (CC and) (PP-TMP (IN at) (NP (NP (CD eight) (NNS intervals)) (PP (IN through) (PP (IN to) (NP (NN birth)))))) (-RRB- -RRB-))) (CC and) (NP (JJ postnatal) (NML (JJ middle) (NN ear)) (NN tissue) (PRN (-LRB- -LRB-) (NP-TMP (CD 13) (NNS DAB)) (, ,) (NP-TMP (CD 21) (NNS DAB)) (-RRB- -RRB-)))))) (PP-PRP (IN in) (NP (NN order) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB relate) (NP (DT the) (VBG underlying) (NN mutation)) (PP (IN to) (NP (DT the) (NN Junbo) (NN phenotype)))))))))))) (. .)) )
( (S (S (NP-SBJ (PRP We)) (VP (VBD examined) (NP (NP (NN expression)) (PP-LOC (IN in) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN Jbo) (HYPH /) (SYM +))) (NNS mice)))))) (, ,) (CC but) (SINV (PP-TMP (IN at) (NP (DT no) (NN time) (NN point))) (VBD did) (NP-SBJ (PRP we)) (VP (VBP identify) (NP (NP (DT any) (JJ significant) (NNS differences)) (PP (IN in) (NP (NN expression) (NNS patterns))) (, ,) (PP-TMP (PP (IN up) (PP (IN to) (NP-1 (-NONE- *RNR*)))) (CC and) (PP (VBG including) (NP-1 (-NONE- *RNR*))) (NP-1 (NN birth)))) (, ,) (PP (IN from) (NP (NP (DT those)) (VP (VBN described) (NP (-NONE- *))))) (PRN (-LRB- [) (NP (CD 14) (, ,) (CD 18)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB However)) (, ,) (PP-LOC (IN in) (NP (JJ postnatal) (NN head) (NNS tissues))) (, ,) (NP-SBJ (PRP we)) (ADVP-TMP (RB now)) (VP (VBP find) (SBAR (SBAR (IN that) (S (NP-SBJ-1 (NN Evi1)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS nuclei)) (PP (IN of) (NP (NP (JJ myeloid) (NNS cells)) (PP-LOC (IN in) (NP (NP (NN bone) (NN marrow)) (, ,) (NP (NN neutrophil) (NNS leukocytes)) (, ,) (NP (NNS fibroblasts)) (, ,) (CC and) (NP (NP (JJ basal) (JJ epithelial) (NNS cells)) (PP-LOC (IN in) (NP (DT the) (JJ inflamed) (NML (JJ middle) (NN ear)) (NN lining)))))))))) (PRN (-LRB- -LRB-) (NP (NN Figure) (CD 4)) (-RRB- -RRB-)))))) (, ,) (CC and) (SBAR (IN that) (S (NP-SBJ (NP (NNS patterns)) (PP (IN of) (NP (NN expression)))) (VP (VBP are) (ADJP-PRD (JJ similar)) (PP-LOC (IN in) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (JJ wild) (HYPH -) (NN type))) (NNS mice)))))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (HEADING (NP (NP (NML (NN Evi1) (NN Protein)) (NN Immunostaining)) (PP-LOC (IN in) (NP (NP (ADJP (NP (CD 13) (HYPH -) (NN d)) (HYPH -) (JJ Old)) (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (JJ Wild) (HYPH -) (NN Type))) (NNS Mice)) (PP (IN with) (NP (JJ Acute) (NN OM))))))) )
( (CAPTION (NP (LST (-LRB- -LRB-) (LS a) (-RRB- -RRB-)) (NP (ADJP (NP (NN Jbo) (HYPH /) (SYM +)) (JJ positive)) (JJ myeloid) (NNS cells)) (PP-LOC (IN in) (NP (NML (JJ temporal) (NN bone)) (NN marrow))) (NP-ADV (SYM ×) (CD 600)) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (-NONE- *0*) (S (NP-SBJ (NNS chondrocytes) (CC and) (NNS osteocytes)) (VP (VBP are) (ADVP (RB also)) (ADJP-PRD (RB strongly) (JJ positive)))))) (. .))) )
( (CAPTION (S (LST (-LRB- -LRB-) (LS b) (-RRB- -RRB-)) (NP-SBJ (NML (NN Jbo) (HYPH /) (SYM +)) (NN mucoperiosteum)) (VP (VBZ has) (NP (NP (NP (JJ positive) (NN neutrophil) (NNS leukocytes)) (, ,) (NP (NNS fibroblasts)) (, ,) (CC and) (NP (NML (ADJP (JJ basal) (JJ epithelial)) (NN cell)) (NNS nuclei))) (NP-ADV (SYM ×) (CD 600)))) (. .))) )
( (CAPTION (NP (NP (LST (-LRB- -LRB-) (LS c) (-RRB- -RRB-)) (NP (NP (NML (SYM +) (HYPH /) (SYM +)) (JJ similar) (NN pattern)) (PP (IN of) (NP (NN staining))) (PP-LOC (IN in) (NP (NN bone) (NN marrow)))) (NP-ADV (SYM ×) (CD 600))) (CC and) (NP (LST (-LRB- -LRB-) (LS d) (-RRB- -RRB-)) (NP (NML (SYM +) (HYPH /) (SYM +)) (JJ inflamed) (NN mucoperiosteum)) (NP-ADV (SYM ×) (CD 600))) (. .))) )
( (CAPTION (NP (NP (NP (NN B)) (, ,) (NP (ADJP (JJ basal) (JJ epithelial)) (NN cell) (NNS nuclei))) (: ;) (NP (NP (NN C)) (, ,) (NP (NN chrondrocyte))) (: ;) (NP (NP (NN F)) (, ,) (NP (NN fibroblast))) (: ;) (NP (NP (NN MC)) (, ,) (NP (JJ myeloid) (NN cell))) (: ;) (NP (NP (NN N)) (, ,) (NP (NN neutrophil) (NN leukocyte))) (: ;) (NP (NP (NN O)) (, ,) (NP (NN osteocyte))))) )
( (HEADING (NP (NP (NN OM) (NN Phenotype)) (PP (IN of) (NP (DT the) (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +)) (NNS Mice))))) )
( (S (NP-SBJ (NN OM)) (VP (VBZ is) (RB not) (NP-PRD (NP (DT a) (JJ prominent) (NN feature)) (PP-LOC (IN in) (NP (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +)) (NNS mice))))) (. .)) )
( (S (S (NP-SBJ (NP (QP (RB Only) (CD one))) (PP (IN of) (NP (NP (CD 12) (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +)) (NNS mice)) (ADJP (SYM >) (NP (CD 68) (NNS DAB)))))) (VP (VBD had) (NP (NN OM)))) (, ,) (CC and) (S (PP (IN in) (NP (DT this) (JJ single) (NN case))) (NP-SBJ (PRP it)) (VP (VBD was) (ADJP-PRD (JJ unilateral)))) (. .)) )
( (S (NP-SBJ (NN OM)) (VP (VBD was) (RB not) (ADJP-PRD (JJ present)) (PP-LOC (IN in) (NP (CD 15) (NML (JJ wild) (HYPH -) (NN type)) (NNS littermates)))) (. .)) )
( (S (NP-SBJ (NP (NP (DT The) (NN absence)) (PP (IN of) (NP (NN OM))) (PP-LOC (IN in) (NP (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +)) (NNS mice)))) (, ,) (VP (VBN coupled) (NP (-NONE- *)) (PP (IN with) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (JJ extra) (NNS digits))) (PP-LOC (IN in) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (NN Jbo) (HYPH /) (NN Jbo))) (NNS mice))))))) (, ,) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (DT the) (NN Junbo) (NN mutation)) (VP (MD may) (VP (VB have) (NP (NML (NML (NN gain)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN function)))) (NNS effects))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (JJ genetic) (NN background)) (PP (IN of) (NP (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +)) (NNS mice)))) (VP (VBZ differs) (PP (IN from) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (NN Jbo) (HYPH /) (NN Jbo))) (NNS mice))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NNS Materials) (CC and) (NNS Methods)))) (-RRB- -RRB-))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (DT the) (NN Evi1tm1Mmor) (NN mutation)) (VP (VBZ is) (NP-PRD (DT an) (ADJP (NN isoform) (HYPH -) (JJ specific)) (NN null))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (S-1 (-NONE- *EXP*))) (VP (VBZ is) (ADVP (RB therefore)) (ADJP-PRD (JJ difficult)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB reach) (NP (NP (JJ definitive) (NNS conclusions)) (PP (IN as) (IN to) (NP (NP (DT the) (NN nature)) (PP (IN of) (NP (DT the) (NN Junbo) (NN mutation)))))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Discussion)))) (-RRB- -RRB-)))))) (. .)) )
( (HEADING (NP (NN Discussion))) )
( (S (NP-SBJ (NP (DT A) (NN mutation)) (PP (IN in) (NP (DT the) (NN Evi1) (NN transcription) (NN factor)))) (VP (VBZ underlies) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (DT a) (JJ chronic) (JJ suppurative) (NN OM))) (PP-LOC (IN in) (NP (DT the) (NN Junbo) (NN mutant))))) (. .)) )
( (S (NP-SBJ-1 (JJ Genetic) (NNS mechanisms)) (VP (VBP appear) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (JJ microbiological) (NN status)) (CC and) (NP (JJ environmental) (NNS conditions)))) (, ,) (SBAR-ADV (JJ such) (IN that) (S (NP-SBJ (NP (JJ SPF) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)) (PP (IN with) (NP (VBN improved) (NN air) (NN quality)))) (VP (VBP have) (NP (JJR milder) (JJ early) (NN OM))))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Gnotobiotic) (NNS studies)) (VP (VBP are) (VP (VBN planned) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NML (NML (JJ nasopharyngeal) (NNP Staphylococcus)) (CC and) (NML (NNP Streptococcus) (NNP spp.))) (NNS commensals))) (PP (IN in) (NP (NN OM) (NN pathogenesis))))))))) (. .)) )
( (S (NP-SBJ (NP (NP (DT The) (NN absence)) (PP (IN of) (NP (NP (JJ multi-systemic) (NN inflammation)) (CC and) (NP (NP (JJ opportunistic) (NNS infections)) (PP-LOC (IN at) (NP (JJ other) (NNS sites))))))) (, ,) (CC and) (NP (NP (DT the) (JJ normal) (ADJP (ADJP (NN T) (HYPH -) (JJ dependent)) (CC and) (ADJP (NN T) (HYPH -) (JJ independent))) (NN immune) (NNS responses)) (PP-LOC (IN in) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))))) (, ,) (VP (VBP argue) (PP (IN against) (S-NOM (NP-SBJ (DT an) (JJ overt) (NN immune) (NN deficiency)) (VP (VBG being) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (NN OM)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN Evi1) (NN locus)) (VP (VBD was) (ADVP-TMP (RB initially)) (VP (VBN identified) (NP-1 (-NONE- *)) (PP (IN as) (NP (NP (NP (DT a) (JJ common) (NN site)) (PP (IN of) (NP (JJ retroviral) (NN integration)))) (VP (VBG underlying) (NP (NP (NN susceptibility)) (PP (IN to) (NP (JJ myeloid) (NNS tumors))))))) (PP-LOC (IN in) (NP (DT the) (NN AKXD) (NN mouse) (JJ recombinant) (JJ inbred) (NN strain))) (PRN (-LRB- [) (NP (CD 19) (, ,) (CD 20)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Transcriptional) (NN activation)) (PP (IN of) (NP (DT the) (NN Evi1) (NN locus))) (PP (IN by) (NP (NNS translocations) (CC and) (NNS inversions)))) (VP (VBZ leads) (PP (IN to) (NP (NP (JJ myeloid) (NNS leukemias)) (CC and) (NP (JJ myelodysplastic) (NN syndrome)))) (PP-LOC (IN in) (NP (NNS humans))) (PRN (-LRB- [) (NP (CD 21)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (DT This) (NN locus)) (VP (VBZ encodes) (NP (NP (DT a) (NML (CD 145) (HYPH -) (NN kDa)) (JJ nuclear) (NN transcription) (NN factor)) (PP (IN with) (NP (NP (CD two) (JJ distinct) (NML (NN zinc) (HYPH -) (NN finger)) (NNS domains)) (VP (VBN composed) (NP (-NONE- *)) (PP (IN of) (NP (NML (CD seven) (CC and) (CD three)) (NML (NN zinc) (HYPH -) (NN finger)) (NNS motifs))) (, ,) (ADVP (RB respectively)) (PRN (-LRB- [) (NP (CD 22)) (-RRB- ]))))))) (. .)) )
( (S (S (NP-SBJ-2 (DT Each) (NML (NN zinc) (HYPH -) (NN finger)) (NN domain)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB bind) (NP (JJ specific) (NN target) (NN consensus) (NN DNA) (NNS sequences))))))))) (, ,) (CC and) (S (NP-SBJ-1 (NP (JJ additional) (ADJP (ADJP (NN proline) (HYPH -) (JJ rich)) (CC and) (ADJP (RB highly) (JJ acidic))) (NNS domains)) (VP (VBN located) (NP (-NONE- *)) (PP-LOC (IN within) (NP (DT the) (NN protein))))) (VP (VBP have) (VP (VBN been) (VP (VBN demonstrated) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ capable) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG repressing) (CC or) (VBG activating) (NP (NML (NN target) (NN promoter)) (NNS activities)) (, ,) (ADVP (RB respectively)))))) (PRN (-LRB- [) (NP (NP (CD 21)) (PP (SYM –) (NP (CD 24)))) (-RRB- ]))))))))) (. .)) )
( (S (NP-SBJ-1 (NN Evi1)) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (JJ capable) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG repressing) (NP (NP (NP (DT the) (NML (NN TGF) (HYPH -) (NN β)) (NN signaling) (NN pathway)) (PP (IN through) (NP (NP (JJ direct) (NN binding)) (PP (IN of) (NP (NN Smad3)))))) (VP (VBN mediated) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (JJ first) (NML (NN zinc) (HYPH -) (NN finger)) (NN domain))) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG suggesting) (NP (NP (DT a) (JJ functional) (NN role)) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP (NN cell) (NML (NN development) (CC and) (NN proliferation))))))) (PRN (-LRB- [) (NP (CD 25)) (-RRB- ])))))))))))))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NML (NN cell) (NN line)) (NNS assays)) (VP (VBP have) (VP (VBN demonstrated) (NP (NP (DT a) (NN role)) (PP (IN for) (NP (NN Evi1))) (PP (IN in) (NP (NP (NP (NP (DT the) (JJ transcriptional) (NN control)) (PP (IN of) (NP (NN c) (HYPH -) (NN fos)))) (CC and) (NP (DT the) (NML (NN AP) (HYPH -) (CD 1)) (JJ proliferative) (NN pathway))) (PP (IN through) (NP (NP (NNS interactions)) (PP (IN of) (NP (DT the) (JJ second) (NML (NN zinc) (HYPH -) (NN finger)) (NN domain)))))))) (PRN (-LRB- [) (NP (CD 26)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (DT The) (NN Junbo) (NN mutation)) (VP (VBZ results) (PP (IN in) (NP (DT a) (JJ nonconservative) (NN Asn763Ile) (NN change))) (PP-LOC (IN in) (NP (NP (DT the) (NN second)) (PP (IN of) (NP (DT these) (CD three) (NN zinc) (HYPH -) (NNS fingers)))))) (. .)) )
( (S (NP-SBJ (NP (JJ Previous) (ADJP (FW in) (FW vitro)) (ADJP (NN site) (HYPH -) (JJ directed)) (NN mutagenesis) (NNS studies)) (PP (IN of) (NP (DT the) (NN contact) (NNS residues))) (PP-LOC (IN within) (NP (DT these) (CD three) (NN zinc) (HYPH -) (NNS fingers)))) (VP (VBD uncovered) (NP (NP (DT a) (JJ complete) (NN loss)) (PP (IN of) (NP (NML (NN DNA) (HYPH -) (NN binding)) (NN ability)))) (PP-TMP (VBG following) (NP (DT any) (NN residue) (NN change))) (PRN (-LRB- [) (NP (CD 23)) (-RRB- ]))) (. .)) )
( (S (S (NP-SBJ (DT The) (NN Junbo) (NN Asn763Ile) (NN alteration)) (VP (VBZ is) (PP-PRD (PP (IN within) (NP (CD three) (NN amino) (NNS acids))) (PP (IN of) (NP (DT a) (NN contact) (NN residue)))))) (, ,) (CC and) (S (NP-SBJ (DT the) (VBN mutated) (NN amino) (NN acid)) (VP (VBZ contributes) (PP (IN to) (NP (NP (DT the) (JJ putative) (NN alpha) (NN helix)) (PP (IN of) (NP (DT the) (NN Cys2His2) (NN structure))))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ-4 (NP (PRP it)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ seems) (S (NP-SBJ-4 (-NONE- *)) (ADJP-PRD (JJ likely))) (SBAR-1 (IN that) (S (NP-SBJ (DT the) (NN Junbo) (NN mutation)) (VP (MD will) (VP (VB disturb) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (DT the) (JJ second) (NML (NN zinc) (HYPH -) (NN finger)) (NN domain))))))))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ unclear)) (SBAR-2 (IN whether) (CC or) (RB not) (S (NP-SBJ (EX there)) (VP (VBP are) (NP-PRD (NP (NNS effects)) (PP (IN on) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (DT the) (JJ first) (NML (NN zinc) (HYPH -) (NN finger)) (NN domain)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ is) (VP (VBN involved) (NP-3 (-NONE- *)) (PP (IN in) (NP (NML (NN TGF) (HYPH -) (NN β)) (NN signaling)))))))))))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (S-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ interesting)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB note) (SBAR (IN that) (S (NP-SBJ (NN OM)) (VP (VBZ is) (RB not) (NP-PRD (NP (NN part)) (PP (IN of) (NP (NP (DT the) (NN phenotype)) (PP (IN of) (NP (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +)) (NNS mice))))))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (DT the) (NN Evi1tm1Mmor) (NN allele)) (VP (VBZ results) (PP (IN in) (NP (NP (DT an) (ADJP (NN isoform) (HYPH -) (JJ specific)) (NN allele)) (PP (IN for) (NP (DT the) (JJS longest) (NN Evi1) (NN transcript))))) (SBAR-ADV (IN while) (S (NP-SBJ (DT the) (NN Δ324) (JJR shorter) (NN isoform)) (VP (VBZ is) (ADJP-PRD (JJ unaffected)))))) (. .)) )
( (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-1 (DT the) (NN Evi1tm1Mmor) (NN knockout)) (VP (VBD was) (VP (VBN established) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NML (NN ES) (HYPH -) (NN D3)) (NNS cells)) (PP (IN with) (NP (NP (NNS chimaeras)) (VP (ADVP-TMP (RB subsequently)) (VBN mated) (NP (-NONE- *)) (PP (IN to) (NP (NML (NN CF) (HYPH -) (CD 1)) (NNS mice)))))))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (CC Both) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (JJR shorter) (NN isoform)))) (CC and) (NP (NP (DT the) (JJ dissimilar) (JJ genetic) (NNS backgrounds)) (PP (IN between) (NP (NP (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +)) (NNS mice)) (CC and) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)))))) (VP (MD may) (VP (VB contribute) (PP (IN to) (NP (NP (DT the) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN expressivity)) (PP (IN of) (NP (DT the) (NN OM) (NN phenotype))))))))) (. .)) )
( (S (ADVP (RB Alternatively)) (, ,) (NP-SBJ-1 (DT the) (NN Junbo) (NN mutation)) (VP (MD may) (VP (VB lead) (PP (IN to) (NP (NML (NML (NN gain)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN function)))) (NNS effects))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (PRP it)) (S-1 (-NONE- *EXP*))) (VP (VBZ is) (RB not) (ADJP-PRD (JJ possible)) (PP-TMP (IN at) (NP (DT this) (NN stage))) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB distinguish) (PP (IN between) (NP (DT these) (NNS possibilities))))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (NN mutation)) (PP-LOC (IN in) (NP (DT the) (NN Evi1) (NN transcription) (NN factor)))) (VP (MD may) (VP (VB give) (NP (NN rise)) (PP (IN to) (NP (NN OM))) (PP-MNR (IN by) (NP (QP (JJR more) (IN than) (CD one)) (NN mechanism))) (, ,) (PP-PRP (VBN given) (SBAR (IN that) (S (NP-SBJ-1 (PRP it)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (JJ different) (NN cell) (NNS types))) (PP-LOC (IN in) (NP (DT the) (JJ middle) (NN ear)))))))))))) (. .)) )
( (S (NP-SBJ (CD One) (NN mechanism)) (VP (VBZ arises) (PP (IN from) (NP (PRP$ our) (NN observation) (SBAR (IN that) (S (NP-SBJ-1 (NN Evi1)) (VP (VBZ is) (VP (VBN expressed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN neutrophil) (NNS leukocytes))) (PP-TMP (IN during) (NP (NN OM) (NN development)))))))))) (. .)) )
( (S (NP-SBJ (NN Evi1)) (VP (VBZ has) (NP (NP (JJ multiple) (NNS functions)) (VP (VBG relating) (PP (IN to) (NP (NP (JJ hematopoietic) (NN differentiation)) (CC and) (NP (NP (NN development)) (PP (IN of) (NP (JJ myeloid) (NN leukemia)))))))) (PRN (-LRB- [) (NP (NP (CD 27)) (PP (SYM –) (NP (CD 30)))) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (CD One) (JJ putative) (NN target) (NN gene)) (PP (IN for) (NP (NN Evi1))) (PP-LOC (IN in) (NP (NN neutrophil) (NNS leukocytes)))) (VP (VBZ is) (NP-PRD (NP (NP (DT the) (NML (NN inositol) (NN triphosphate)) (NML (NN type) (CD 2)) (NN receptor) (NN gene)) (-LRB- -LRB-) (NP (NN Itpr2))) (-RRB- -RRB-) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (VP (VBN required) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NP (JJ functional) (NN regulation)) (PP (IN of) (NP (NN neutrophil) (NN leukocyte) (NN maturation))) (PP (IN via) (NP (NML (NN F) (HYPH -) (NN met) (HYPH -) (NN leu) (HYPH -) (NN phe)) (NN receptor) (NN signaling))) (PP (IN in) (NP (NP (NN response)) (PP (IN to) (NP (JJ bacterial) (NN proteins))))))) (PRN (-LRB- [) (NP (CD 31)) (-RRB- ])))))))) (. .)) )
( (S (NP-SBJ (NP (PRP$ Our) (NN FACS) (NN analysis)) (PP (IN of) (NP (VBG circulating) (NNS neutrophils))) (PP-TMP (IN at) (NP (NP (CD two) (NN time) (NNS points)) (, ,) (SBAR (SBAR (WHADVP-2 (WRB when)) (S (NP-SBJ (NN OM)) (ADVP-TMP (RB first)) (VP (VBZ appears) (ADVP-TMP-2 (-NONE- *T*))))) (CC and) (SBAR (WHADVP-1 (WRB when)) (S (NP-SBJ (JJ chronic) (JJ suppurative) (NN OM)) (VP (VBZ is) (ADJP-PRD (RB well) (VBN established)) (ADVP-TMP-1 (-NONE- *T*))))))))) (, ,) (VP (VBZ indicates) (SBAR (IN that) (S (NP-SBJ (NP (VBN localized) (NN inflammation)) (PP-LOC (IN in) (NP (NP (DT the) (JJ middle) (NN ear)) (PP-LOC (IN in) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)))))) (VP (VBZ does) (RB not) (VP (VB result) (PP (IN in) (NP (JJ significant) (NN neutrophilia)))))))) (. .)) )
( (S (S (NP-SBJ-1 (NNS Neutrophils)) (VP (VBP are) (ADVP (RB apparently)) (VP (VBN released) (NP-1 (-NONE- *)) (PP (IN from) (NP (JJ hematopoietic) (NNS tissues))) (PP (IN at) (NP (JJ comparable) (NNS levels))) (PP-LOC (IN in) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (JJ wild) (HYPH -) (NN type))) (NNS mice)))))) (CC and) (S (NP-SBJ (EX there)) (VP (VBD was) (NP-PRD (NP (DT no) (JJ detectable) (NN block)) (PP (IN in) (NP (NN neutrophil) (NN development)))) (PP-LOC (IN in) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NN ratio)) (PP (IN of) (NP (JJ immature) (NNS neutrophils))) (PP-LOC (IN in) (NP (DT the) (VBG circulating) (NN pool)))) (VP (VBD was) (ADJP-PRD (DT no) (JJR higher)))) (: ;) (S (ADVP (RB indeed)) (, ,) (NP-SBJ-1 (PRP it)) (VP (VBZ is) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (RB recently) (VBN weaned)) (NNS mice))) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ (QP (SYM ~) (CD 60)) (NN %)) (VP (VBP have) (NP (JJ acute) (NN OM)) (ADVP-TMP-3 (-NONE- *T*)))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (NP (JJR older) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)) (PP (IN with) (NP (ADJP (RB fully) (JJ penetrant)) (JJ chronic) (JJ suppurative) (NN OM))))) (, ,) (NP-SBJ (ADJP (JJ immature) (CC and) (JJ mature)) (NN neutrophil) (NNS ratios)) (VP (VBP are) (RB not) (ADVP (RB significantly)) (ADJP-PRD (JJ different) (PP (IN from) (NP (NML (JJ wild) (HYPH -) (NN type)) (NNS mice))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (NN variety)) (PP (IN of) (NP (ADJP (FW in) (FW vitro)) (NNS studies)))) (VP (VBP have) (VP (VP (VBN highlighted) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT the) (NML (NN TGFβ) (HYPH /) (NN SMAD)) (NN pathway))) (PP (IN on) (NP (NN mucin) (NN expression))))) (CC and) (VP (ADVP (RB thus)) (VBD underlined) (NP (NP (DT the) (JJ potential) (NN importance)) (PP (IN of) (NP (DT this) (NN signaling) (NN pathway))) (PP (IN in) (NP (NN OM)))) (PRN (-LRB- [) (NP (CD 32)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (NN loss)) (PP (IN of) (NP (NN Evi1) (NN function)))) (VP (MD could) (VP (VB affect) (NP (NML (NN TGFβ) (HYPH /) (NN SMAD)) (NN signaling) (NNS pathways)))) (. .)) )
( (S (NP-SBJ (EX There)) (VP (VBP are) (NP-PRD (NP (CD two) (ADJP (FW in) (FW vitro)) (NNS studies)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NN Evi1) (NNS mutations)) (VP (MD could) (VP (VB affect) (NP (NP (NN mucin) (NN expression)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD might) (VP (VB underlie) (NP (NP (NN predisoposition)) (PP (IN to) (NP (NN OM)))))))))))))))))) (. .)) )
( (S (ADVP (RB Firstly)) (, ,) (NP-SBJ (NP (NP (JJ nontypeable) (NNP Haemophilus) (NNPS influenzae)) (-LRB- -LRB-) (NP (NN NTHi))) (-RRB- -RRB-) (, ,) (NP (NP (DT a) (JJ known) (JJ bacterial) (NN pathogen)) (VP (VBN involved) (NP (-NONE- *)) (PP-LOC (IN in) (NP (JJ human) (NN OM)))))) (, ,) (VP (VBZ activates) (NP (NP (NML (NML (NN Tgfβ) (NN receptor)) (HYPH -) (NML (NN Smad3) (HYPH /) (CD 4))) (NN signaling)) (SBAR (WHNP-1 (WDT that)) (S (ADVP (RB together) (PP (IN with) (NP (NP (ADJP (NP (NN TLR2) (HYPH -) (NN MyD88) (HYPH -) (NN TAK1) (HYPH -) (NN NIK) (HYPH -) (NN IKKβ) (HYPH /) (NN γ) (HYPH -) (NN IκBα)) (HYPH -) (JJ dependent)) (NN activation)) (PP (IN of) (NP (NN NF) (HYPH -) (NN κB)))))) (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (VP (VBN known) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB mediate) (NP (ADJP (NN NTHi) (HYPH -) (VBN induced)) (NN MUC2) (NN mucin) (NN transcription)))))))))) (PRN (-LRB- [) (NP (CD 33)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NN Evi1) (NML (NML (NN loss)) (HYPH -) (PP (IN of) (HYPH -) (NP (NN function)))) (NNS mutations)) (VP (MD might) (VP (VB lead) (PP (IN to) (NP (NP (NP (DT a) (NN de-repression)) (PP (IN of) (NP (DT the) (NML (NN TGFβ) (HYPH /) (NN SMAD)) (NN pathway)))) (CC and) (NP (NP (NP (DT an) (NN upregulation)) (PP (IN of) (NP (NN MUC2) (NN expression)))) (VP (VBG leading) (PP (IN to) (NP (NP (DT an) (NN enhancement)) (PP (IN of) (NP (JJ effusive) (NNS processes))) (PP (IN as) (NP (NP (DT a) (NN contributor)) (PP (IN to) (NP (NN OM))))))))))))) (. .)) )
( (S (ADVP (RB Alternatively)) (, ,) (NP-SBJ-1 (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (VP (VBN shown) (NP-1 (-NONE- *)) (SBAR-2 (IN that) (S (NP-SBJ (NN NTHi)) (VP (VBZ upregulates) (NP (NN MUC5AC) (NN mucin) (NN production)) (PP-MNR (IN via) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (ADJP (NP (NN TLR2) (HYPH -) (NN MyD88)) (HYPH -) (JJ dependant)) (NN p38) (NN pathway)))))))) (PRN (-LRB- [) (NP (CD 34)) (-RRB- ]))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (NN activation)) (PP (IN of) (NP (NML (NN TGFβ) (HYPH /) (NN SMAD)) (NN signaling))) (PP (IN by) (NP (NN NTHi)))) (ADVP (RB also)) (VP (VBZ leads) (PP (IN to) (NP (NP (JJ down) (HYPH -) (NN regulation)) (PP (IN of) (NP (NN p38) (NN activity))))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VP (VBG inducing) (NP (NN MAPK) (NN phosphatase) (HYPH -) (CD 1))) (CC and) (VP (VBG suppressing) (NP (NML (NN MUC5AC) (NN mucin)) (NN induction))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (PP (IN in) (NP (DT this) (NN case))) (NP-SBJ (NP (NP (NN loss)) (PP (IN of) (NP (NN Evi1) (NN function)))) (CC and) (NP (NP (NN de-repression)) (PP (IN of) (NP (DT the) (NML (NN TGFβ) (HYPH /) (NN SMAD)) (NN pathway))))) (VP (MD would) (ADVP (RB presumably)) (VP (VB lead) (PP (IN to) (NP (NP (NP (VBN increased) (NN suppression)) (PP (IN of) (NP (NML (NN MUC5AC) (NN mucin)) (NN induction)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD may) (VP (VB reduce) (NP (JJ mucociliary) (NN defense)) (PP (IN in) (NP (JJ suppurative) (NN OM))))))))))) (. .)) )
( (S (ADVP (RB Importantly)) (, ,) (NP-SBJ (NP (DT the) (NN identification)) (PP (IN of) (NP (DT the) (NN Junbo) (NN mutation)))) (ADVP-TMP (RB now)) (VP (VBZ provides) (NP (NP (NML (FW in) (FW vivo)) (NN evidence)) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (TO to) (VP (VB support) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (DT these) (NN signaling) (NNS pathways))) (PP (IN in) (NP (NN OM)))))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (S-1 (-NONE- *EXP*))) (VP (MD will) (VP (VB be) (ADJP-PRD (JJ interesting)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (VP (TO to) (VP (VB explore) (ADVP (RB further)) (NP (NP (DT the) (JJ molecular) (NN phenotype)) (PP (IN of) (NP (DT the) (NN Junbo) (NN mutant)))))) (CC and) (VP (TO to) (VP (VB examine) (SBAR (IN whether) (S (NP-SBJ (NP (NN disregulation)) (PP (IN of) (NP (NN mucin) (NN expression)))) (VP (VBZ is) (NP-PRD (NP (DT a) (VBG contributing) (NN factor)) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NN OM))))))))))))))) (. .)) )
( (S (NP-SBJ (NP (NP (JJ Additional) (NNS levels)) (PP (IN of) (NP (NP (NN complexity)) (PP (IN of) (NP (NN Evi1) (NN function)))))) (ADJP (JJ relevant) (PP (IN to) (NP (NN OM) (NN pathogenesis))))) (VP (MD may) (VP (VB result) (PP (IN from) (NP (NP (DT the) (ADJP (JJ first) (PRN (-LRB- -LRB-) (ADJP (NN N) (HYPH -) (JJ terminal)) (-RRB- -RRB-))) (NML (NN zinc) (HYPH -) (NN finger)) (NN domain)) (VP (VBG binding) (PP (IN to) (NP (NP (NP (DT a) (NN number)) (PP (IN of) (NP (JJ putative) (NN target) (NNS genes)))) (NP (NP (NN Gadd45g)) (, ,) (NP (NN Gata2)) (, ,) (NP (NN Zfpm2) (HYPH /) (NN Fog2)) (, ,) (NP (NN Skil) (PRN (-LRB- -LRB-) (NP (NN SnoN)) (-RRB- -RRB-))) (, ,) (NP (NN Klf5) (PRN (-LRB- -LRB-) (NP (NN BTEB2)) (-RRB- -RRB-))) (, ,) (NP (NN Dcn)) (, ,) (CC and) (NP (NN Map3k14) (PRN (-LRB- -LRB-) (NP (NN Nik)) (-RRB- -RRB-))))))))) (PRN (-LRB- [) (NP (CD 35)) (-RRB- ])))) (. .)) )
( (S (PP (IN For) (NP (NN instance))) (, ,) (NP-SBJ (NP (NN Evi1) (NN regulation)) (PP (IN of) (NP (NN Nik)))) (VP (MD could) (VP (VB act) (PP (PP (IN in) (NP (NP (NP (DT the) (ADJP (NP (NN TLR2) (HYPH -) (NN MyD88) (HYPH -) (NN TAK1) (HYPH -) (NN NIK) (HYPH -) (NN IKKβ) (HYPH /) (NN γ) (HYPH -) (NN IκBα)) (HYPH -) (JJ dependent)) (NN activation)) (PP (IN of) (NP (NML (NN NF) (HYPH -) (NN κB)) (NN pathway)))) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB mediate) (NP (ADJP (NN NTHi) (HYPH -) (VBN induced)) (NML (NN MUC2) (NN mucin)) (NN transcription)) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN described) (NP-1 (-NONE- *)) (ADVP (RB above))))))))))) (: ;) (CONJP (CC and) (RB also)) (PP (IN in) (NP (NP (DT the) (ADJP (AFX pro) (JJ inflammatory)) (NML (NN cytokine) (NN IL) (HYPH -) (CD 1)) (NN signaling) (NN pathway)) (NP (NN IL) (HYPH -) (NN 1R1) (HYPH -) (NN MyD88) (HYPH -) (NN IRAK) (HYPH -) (NN TRAF6) (HYPH -) (NN TAK1) (HYPH -) (NN NIK) (HYPH -) (NN IKK) (HYPH -) (NN NF) (HYPH -) (NN κB) (HYPH /) (NN IκB))))) (PRN (-LRB- [) (NP (CD 36)) (-RRB- ])))) (. .)) )
( (S (PP (IN In) (NP (NN conclusion))) (, ,) (NP-SBJ (DT the) (NN Junbo) (NN mutant)) (VP (VBZ provides) (NP (NP (DT an) (JJ important) (JJ genetic) (NN disease) (NN model)) (PP (IN of) (NP (NN OM)))) (: ;) (SBAR-PRP (ADVP (RB particularly)) (IN because) (S (NP-SBJ (PRP it)) (VP (VBZ shares) (NP (JJ important) (NNS features)) (PP (IN with) (NP (DT the) (JJ chronic) (JJ human) (NN condition)))))) (PRN (-LRB- [) (NP (CD 7)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (JJ Inflammatory) (NN disease)) (VP (VP (VBZ is) (ADJP-PRD (JJ restricted) (PP (IN to) (NP (DT the) (JJ middle) (NN ear))))) (CC and) (VP (VBZ is) (RB not) (NP-PRD (NP (DT a) (NN consequence)) (PP (IN of) (NP (JJ overt) (JJ immune) (NN deficiency)))))) (. .)) )
( (S (NP-SBJ (NN OM)) (VP (VP (VBZ arises) (ADVP-TMP (RB spontaneously)) (PP-TMP (IN in) (NP (DT the) (JJ postnatal) (NN period)))) (, ,) (VP (VBZ develops) (PP (IN into) (NP (NP (JJ chronic) (JJ suppurative) (NN OM)) (PP (IN with) (NP (NN otorrhea))))) (, ,) (SBAR-ADV (IN with) (S (NP-SBJ (NP (DT the) (JJ early) (NN severity)) (CC and) (NP (NP (NN age)) (PP (IN of) (NP (NN onset))))) (ADJP-PRD (JJ dependent) (PP (IN on) (NP (NP (JJ microbiological) (NN status)) (CONJP (CC and) (HYPH /) (CC or)) (NP (NN air) (NN quality))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ (NP (DT a) (NN mutation)) (PP-LOC (IN at) (NP (DT the) (NN Evi1) (NN locus)))) (VP (VBZ underlies) (NP (NP (DT the) (NML (NN susceptibility) (CC and) (NN persistence))) (PP (IN of) (NP (NN OM))))))))) (. .)) )
( (S (NP-SBJ (PRP$ Our) (NNS observations)) (VP (VBP underline) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN Evi1))) (PP (IN in) (NP (NML (NN mucin) (NN gene)) (NN regulation)))) (PP (IN as) (NP (NP (DT a) (JJ possible) (NN contributor)) (PP (IN to) (NP (NN OM)))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN regard))) (, ,) (NP-SBJ-1 (NP (DT the) (NN Evi1) (NN gene)) (CC and) (NP (VBN associated) (NN pathway) (NNS members))) (VP (MD can) (VP (VB be) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (NP-PRD (NP (JJ important) (NNS candidates)) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG examining) (NP (NP (DT the) (JJ genetic) (NN basis)) (PP (IN for) (NP (NP (NN susceptibility)) (PP (IN to) (NP (NN OM)))))) (PP-LOC (IN in) (NP (DT the) (JJ human) (NN population))))))))))) (. .)) )
( (HEADING (NP (NNS Materials) (CC and) (NNS Methods))) )
( (HEADING (NP (NP (NNS Mice)) (CC and) (NP (NN deafness) (NN screening)) (. .))) )
( (S (NP-SBJ-1 (NP (DT The) (NN founder) (NN mouse)) (VP (VBG carrying) (NP (DT the) (NN Junbo) (NN mutation)))) (VP (VBD was) (VP (VBN generated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT a) (NML (JJ large) (HYPH -) (NN scale)) (NML (NN ENU) (NN mutagenesis)) (NN program))) (PP-LOC (IN at) (NP (NP (NNP Harwell)) (, ,) (NP-LOC (NNP United) (NNP Kingdom)))) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ-1 (JJ Male) (NML (NN BALB) (HYPH /) (NN c)) (NNS mice)) (VP (VBD were) (VP (VBN mutagenized) (CC and) (VBN mated) (NP-1 (-NONE- *)) (PP (IN to) (NP (JJ normal) (NML (NN C3H) (HYPH /) (NN HeN)) (NNS females)))))) (, ,) (CC and) (S (NP-SBJ-2 (DT the) (NN offspring)) (VP (VBD were) (VP (VBN screened) (NP-2 (-NONE- *)) (PP (IN for) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS defects))) (, ,) (PP (VBG including) (NP (NP (NN deafness)) (CC and) (NP (JJ vestibular) (NN dysfunction))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN Jbo) (NN founder)) (VP (VBD was) (VP (VBN identified) (NP-1 (-NONE- *)) (PP-PRP (IN because) (IN of) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (DT a) (NNP Preyer) (NN reflex))))) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBN presented) (NP-2 (-NONE- *)) (PP (IN with) (NP (DT a) (VBN calibrated) (NML (CD 20) (NN kHz)) (NML (CD 90) (NN dB)) (NN SPL) (NN tone) (NN burst))) (ADVP-TMP-3 (-NONE- *T*))))))) (. .)) )
( (S (PP (IN For) (NP (NP (NN analysis)) (PP (IN of) (NP (DT the) (NN phenotype))))) (, ,) (NP-SBJ-1 (DT the) (NN colony)) (VP (VBD was) (VP (VBN maintained) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (NN C3H) (HYPH /) (NN HeN)) (NN background))) (PP-MNR (IN in) (NP (NP (NN accordance)) (PP (IN with) (NP (NML (NNP Home) (NNP Office)) (NNS regulations))))))) (. .)) )
( (HEADING (NP (NP (JJ Microbiological) (NN status)) (PP (IN of) (NP (DT the) (NNS mice))) (. .))) )
( (S (NP-SBJ-1 (NN Junbo) (NNS mice)) (VP (VBD were) (ADVP-TMP (RB originally)) (VP (VBN derived) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (DT a) (JJ conventional) (NN facility))))) (. .)) )
( (S (NP-SBJ (NP (NN Sentinel) (NNS mice)) (PP (IN from) (NP (DT this) (NN colony)))) (VP (VBD were) (ADJP-PRD (JJ seropositive) (PP (IN for) (NP (NP (NP (NP (DT the) (ADJP (NP (NN FELASA) (HYPH -) (PRN (-LRB- [) (NP (CD 37)) (-RRB- ]))) (VBN listed)) (JJ viral) (NNS agents) (NN MHV)) (-LRB- -LRB-) (VP (VBN judged) (PP (IN by) (NP-LGS (NN histology))) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (JJ enteropathic) (NNS strains))))))) (-RRB- -RRB-) (, ,) (NP (NN Adenovirus) (CD II)) (, ,) (CC and) (NP (NN TMEV))) (, ,) (SBAR (WHNP-1 (NP (NN none)) (WHPP (IN of) (WHNP (WDT which)))) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (NP-PRD (JJ primary) (JJ respiratory) (NNS pathogens)) (PRN (-LRB- [) (NP (CD 38)) (-RRB- ]))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Intestinal) (NNS flagellates)) (, ,) (NP (NNS pinworms)) (, ,) (CC and) (NP (NP (DT the) (JJ opportunist) (JJ respiratory) (NN pathogen)) (NP (NNP Pasteurella) (NNP pneumotropica)))) (VP (VBD were) (ADVP (RB also)) (NP-PRD (JJ common) (NNS isolates))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NN number)) (PP (IN of) (NP (NP (NP (NNS pathogens)) (VP (VBN known) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB cause) (NP (NP (JJ respiratory) (NN disease)) (CONJP (CC and) (HYPH /) (CC or)) (NP (NN OM))) (PP-LOC (IN in) (NP (DT the) (NN mouse)))))))) (PP (JJ such) (IN as) (NP (NP (NN pneumonia) (NN virus)) (, ,) (NP (NNP Sendai) (NN virus)) (, ,) (NP (NN Mycoplasma) (NN pulmonis)) (, ,) (NP (NNP Streptococcus) (NNP pneumoniae)) (, ,) (CC and) (NP (NNP Pseudomonas) (NNP aeruginosa))))))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN found) (NP-1 (-NONE- *)) (PP-TMP (IN over) (NP (JJ many) (NNS years))) (PP (IN in) (NP (DT the) (NN sentinel) (NNS screens)))))) (. .)) )
( (S (NP-SBJ (NP (ADJP (JJ Non-FELASA) (HYPH -) (VBN listed)) (NNS bacteria)) (VP (VBN isolated) (NP (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NN nasopharynx)) (PP (IN of) (NP (NN sentinel) (NNS mice))))))) (VP (VBP include) (NP (NP (NNP Staphylococcus) (NNP spp.)) (, ,) (NP (NNP Staphylococcus) (NNP aureus)) (, ,) (NP (ADJP (NNP Alpha) (HYPH -) (NNP haemolytic)) (NNPS streptococci)) (, ,) (CC and) (NP (JJ other) (NNP Streptococcus) (NN spp)))) (. .)) )
( (S (NP-SBJ-1 (NN Junbo) (NNS mice)) (VP (VBP are) (ADVP-TMP (RB now)) (VP (VBN housed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NP (DT a) (NML (JJ high) (HYPH -) (NN health) (HYPH -) (NN status)) (JJ SPF) (NN unit)) (SBAR (WHPP-3 (IN in) (WHNP (WDT which))) (S (NP-SBJ-2 (DT all) (ADJP (NN FELASA) (HYPH -) (VBN listed)) (NNS pathogens)) (VP (VBP have) (VP (VBN been) (VP (VBN excluded) (NP-2 (-NONE- *)) (PP-LOC-3 (-NONE- *T*))))))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Non-FELASA) (JJ nasopharyngeal) (NNS flora)) (VP (VBZ remains) (S (NP-SBJ-1 (-NONE- *)) (NP-PRD (DT the) (JJ same)))) (. .)) )
( (HEADING (NP (JJ Genetic) (NML (NNS crosses) (CC and) (NN mapping)) (. .))) )
( (S (NP-SBJ-1 (DT The) (NN founder) (NML (NN C3HeNBALB) (HYPH /) (NN cENUF1) (HYPH -) (NN Jbo) (HYPH /) (SYM +)) (NN mouse)) (VP (VBD was) (VP (VBN maintained) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (VBN repeated) (VBG backcrossing)) (PP (IN to) (NP (NN C3H) (HYPH /) (NN HeN))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Mutant) (NN progeny)) (VP (VBD were) (VP (VBN identified) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (DT the) (NN lack)) (PP (IN of) (NP (DT a) (NNP Preyer) (NN reflex))))))) (. .)) )
( (S (S (NP-SBJ-1 (CD 41) (NNS DNAs)) (VP (VBD were) (ADVP-TMP (RB initially)) (VP (VBN pooled) (NP-1 (-NONE- *)) (PP (IN from) (NP (VBN affected) (NNS individuals)))))) (CC and) (S (NP-SBJ-2 (DT a) (NN genome) (NN scan)) (VP (VBD was) (VP (VBN carried) (NP-2 (-NONE- *)) (PRT (RP out)) (SBAR-MNR (IN as) (S (NP-SBJ-3 (-NONE- *PRO*)) (VP (VBN described) (NP-3 (-NONE- *)) (PRN (-LRB- [) (NP (CD 9) (, ,) (CD 13)) (-RRB- ])))))))) (. .)) )
( (S (NP-SBJ-1 (DT A) (NML (JJ high) (HYPH -) (NN resolution)) (JJ genetic) (NN map)) (VP (VBD was) (VP (VBN constructed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (CD 242) (NML (JJ affected) (NN progeny)) (NML (NN N4) (CC and) (NN N5)) (NN backcross) (NN progeny)))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NML (VBN published) (NN microsatellite) (NNS markers)) (NML (NN D3Mit90) (, ,) (NN D3Mit328) (, ,) (NN D3Mit92) (, ,) (NN D3Mit203) (, ,) (NN D3Mit55) (, ,) (NN D3Mit178) (, ,) (NN D3Mit151) (, ,) (NN D3Mit273) (, ,) (NN D3Mit180) (, ,) (NN D3Mit239) (, ,) (NN D3Mit21) (, ,) (NN D3Mit224) (, ,) (NN D3Mit182) (, ,) (NN D3Mit119) (, ,) (NN D3Mit241) (, ,) (CC and) (NN D3Mit22))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ genetic) (NN map)) (PP (IN across) (NP (DT the) (NN Jbo) (NN locus)))) (VP (VBD was) (VP (VBN constructed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG minimizing) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NN recombination) (NNS events)))) (PP-LOC (IN across) (NP (DT the) (NN region)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN Evi1tm1Mmor) (NN mutation)) (VP (VBD was) (VP (VBN generated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN D3) (NN ES)) (NNS cells))) (PP (IN with) (NP (NP (JJ subsequent) (NNS matings)) (PP (IN to) (NP (NML (NN CF) (HYPH -) (CD 1)) (NNS mice))))) (PRN (-LRB- [) (NP (CD 14)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +)) (NNS mice)) (VP (VBD were) (VP (VBN mated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NML (NN C3H) (HYPH /) (NN HeN)) (NNS mice))) (PP-TMP (IN before) (NP (NP (NN crossing)) (PP (IN to) (NP (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))))) (PP-PRP (IN for) (NP (NN complementation) (NN testing))))) (. .)) )
( (S (PP-PRP (IN For) (NP (JJ phenotypic) (NN analysis))) (NP-SBJ-1 (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +)) (NNS mice)) (VP (VBD were) (ADVP (RB also)) (VP (VBN mated) (NP-1 (-NONE- *)) (PP (IN to) (NP (NP (NP (NML (NN C3H) (HYPH /) (NN HeN)) (NNS mice)) (CC and) (NP (NN F1) (JJ heterozygous) (JJ mutant) (NN progeny))) (PP (IN along) (PP (IN with) (NP (NP (NML (JJ wild) (HYPH -) (NN type)) (JJ littermate) (NNS controls)) (VP (VBN aged) (NP (-NONE- *)) (PP (IN to) (NP (JJ appropriate) (NN time) (NNS points))))))))))) (. .)) )
( (HEADING (NP (NP (NN Pathology)) (, ,) (NP (NN histology)) (, ,) (CC and) (NP (NN X-Ray) (NN analysis)) (. .))) )
( (S (NP-SBJ-1 (NP (DT The) (NML (NML (NN onset)) (CC and) (NML (NN time) (NN course)))) (PP (IN of) (NP (NP (NN development)) (PP (IN of) (NP (DT the) (NML (JJ middle) (NN ear)) (NN disease)))))) (VP (VBD was) (VP (VBN examined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN histology))) (UCP (PP-LOC (IN in) (NP (NP (ADJP (RB conventionally) (VBN housed)) (JJ postnatal) (NNS mice)) (NP-TMP (QP (CD 4) (SYM –) (CD 5)) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD five) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD two) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))))) (: ;) (NP-TMP (JJ postnatal) (CD 13) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD 13) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD 16) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (: ;) (PP-TMP (IN at) (NP (NP (VBG weaning)) (NP-TMP (CD 21) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD seven) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD 17) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))))) (: ;) (CC and) (PP-LOC (IN in) (NP (NP (JJ adult) (NNS mice)) (NP-TMP (NP (CD 29) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD five) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD 11) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (NP (CD 44) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD six) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD eight) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (NP (CD 180) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD seven) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD nine) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (CC and) (NP (QP (CD 180) (SYM –) (CD 360)) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD six) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD three) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Representative) (NNS mice)) (PP (IN from) (NP (QP (CD one) (IN to) (CD three)) (NNS litters)))) (VP (VBD were) (VP (VBN examined) (NP-1 (-NONE- *)) (PP-TMP (IN at) (NP (DT each) (NN time) (NN point))))) (. .)) )
( (S (PP (IN In) (NP (NP (DT a) (JJ second) (NN study)) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (TO to) (VP (VB assess) (NP (DT the) (NN OM) (NN phenotype)) (PP (IN under) (NP (JJ SPF) (NNS conditions))))))))) (, ,) (NP-SBJ-2 (NN Junbo) (NNS mice)) (VP (VBD were) (VP (VBN sampled) (NP-2 (-NONE- *)) (PP (IN from) (NP (NP (DT an) (NN embryo) (VBN re-derived) (NN colony)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBD was) (VP (VBN housed) (NP-3 (-NONE- *)) (PP-LOC (IN in) (NP (ADJP (RB individually) (VBN ventilated)) (NNS cages))))))))))) (. .)) )
( (FRAG (S (NP-SBJ (DT The) (NNS cohorts)) (VP (VBD were) (SBAR-PRD (IN as) (S (NP-SBJ (-NONE- *PRO*)) (VP (VBZ follows)))))) (: :) (NP (NP (CD 5) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD four) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD nine) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (NP (CD 13) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD 11) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD 19) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (NP (QP (CD 20) (SYM –) (CD 22)) (NNS DAB)) (, ,) (NP (CD 28) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD 24) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD 17) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (NP (QP (CD 49) (SYM –) (CD 58)) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD 20) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD 18) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (CC and) (NP (QP (CD 85) (SYM –) (CD 115)) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD 19) (NN Jbo) (HYPH /) (SYM +)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (NP (CD 12) (ADJP (RB conventionally) (VBN housed)) (NML (CD 68) (HYPH -) (NNS DAB)) (NML (NN Evi1tm1Mmor) (HYPH /) (SYM +)) (NNS mice)) (CC and) (NP (CD 15) (ADJP (JJ same) (HYPH -) (VBN aged)) (NML (JJ wild) (HYPH -) (NN type)) (NNS littermates))) (VP (VBD were) (RB also) (VP (VBN examined) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN OM))))) (. .)) )
( (S (NP-SBJ-1 (NNS Tissues)) (VP (VBD were) (VP (VP (VBN fixed) (NP-1 (-NONE- *)) (NP-TMP (QP (CD 24) (SYM –) (CD 48)) (NNS h)) (PP-LOC (IN in) (NP (NML (CD 10) (NN %)) (NML (NML (JJ neutral) (VBN buffered) (NN formalin)) (-LRB- -LRB-) (NML (NN NBF)))))) (-RRB- -RRB-) (CC and) (VP (VBN embedded) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN paraffin) (NN wax)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Heads) (CC and) (NNS bones)) (VP (VBD were) (VP (VBN decalcified) (NP-1 (-NONE- *)) (NP-TMP (QP (CD 24) (SYM –) (CD 48)) (NNS h)) (PP-MNR (IN with) (NP (NNP Immunocal) (PRN (-LRB- -LRB-) (NP (NP (NNP Decal) (NNP Corporation)) (, ,) (NP-LOC (NNP Tallman)) (, ,) (NP-LOC (NNP New) (NNP York)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NML (CD 4) (HYPH -) (NN μm)) (NML (JJ dorsal) (NN plane)) (NNS sections)) (PP (IN of) (NP (VBN decalcified) (JJ middle) (NNS ears)))) (VP (VBD were) (VP (VBN stained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NN Haemotoxylin) (CC and) (NN Eosin)) (-LRB- -LRB-) (NP (NN H) (CC &) (NN E)))))) (-RRB- -RRB-) (. .)) )
( (S (PP-LOC (IN In) (NP (NP (NML (NML (CD 13) (HYPH -) (CC and) (CD 21)) (HYPH -) (NNS DAB)) (NNS mice)) (PP (IN with) (NP (NN OM))))) (, ,) (NP-SBJ-1 (NP (NP (JJ transverse) (NNS sections)) (PP (IN of) (NP (DT the) (JJ nasal) (NNS turbinates)))) (, ,) (NP (NP (NML (JJ dorsal) (NN plane)) (NNS sections)) (PP (IN of) (NP (DT the) (NML (NN oropharynx) (, ,) (NNS lungs) (, ,) (NNS livers) (, ,) (NNS kidneys) (, ,) (NN heart) (, ,) (NN spleen) (, ,) (NNS intestines) (, ,) (NN pancreas) (, ,) (CC and) (NNS livers)))))) (VP (VBD were) (VP (VBN examined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN histology))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Sections)) (PP (IN of) (NP (NP (JJ middle) (NNS ears)) (, ,) (NP (NNS snouts)) (, ,) (CC and) (NP (NNS lungs)))) (PP (IN from) (NP (NN OM) (NNS cases)))) (VP (VBD were) (VP (VBN examined) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NNS bacteria))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (NN Gram) (NN stain)) (CC and) (NP (NNP Sirius) (NN red))) (PP (IN for) (NP (NN eosinophil) (NNS leukocytes))))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB assess) (NP (NP (DT the) (NN possibility)) (PP (IN of) (NP (JJ opportunistic) (NNS infections)))) (PP-LOC (IN at) (NP (JJ other) (NN body) (NNS sites)))))) (, ,) (NP-SBJ-1 (DT a) (JJ general) (NN pathology) (NN screen)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-LOC (IN on) (NP (NP (NP (CD four) (NML (CD 28) (HYPH -) (NNS DAB)) (NML-2 (-NONE- *RNR*))) (CC and) (NP (CD seven) (NML (CD 56) (HYPH -) (NNS DAB)) (NML-2 (-NONE- *RNR*)))) (NML-2 (JJ SPF) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice)))))) (. .)) )
( (S (S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-2 (NP (DT a) (ADJP (RBR more) (JJ extensive)) (NML (JJ whole) (HYPH -) (NN body)) (NN pathology) (NN analysis)) (PP (IN of) (NP (NML (CD 25) (SYM +)) (NNS tissues))) (PP (VBG following) (NP (NN EMPReSS) (NN necropsy) (NNS SOPs)) (PRN (-LRB- [) (NP (CD 39)) (-RRB- ])))) (VP (VBD was) (VP (VBN performed) (NP-2 (-NONE- *)) (PP-LOC (IN on) (NP (NP (CD four) (JJ female) (NML-3 (-NONE- *RNR*))) (CC and) (NP (CD three) (JJ male) (NML-3 (-NONE- *RNR*))) (NML-3 (NML (CD 180) (HYPH -) (NNS DAB)) (NML (NN Jbo) (HYPH /) (SYM +)) (NNS mice))))))) (: ;) (S (NP-SBJ-1 (NP (CD five) (JJ female) (NML-4 (-NONE- *RNR*))) (CC and) (NP (CD four) (JJ male) (NML-4 (-NONE- *RNR*))) (NML-4 (NML (JJ wild) (HYPH -) (NN type)) (NN litter) (NNS mates))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN as) (NP (NNS controls)))))) (. .)) )
( (S (PP (IN For) (NP (NN X-ray) (NN analysis))) (, ,) (S (S (NP-SBJ-1=4 (NNS heads)) (VP (VBD were) (VP=3 (VBN skinned) (NP-1 (-NONE- *))))) (CC and) (S (NP-SBJ-2=4 (DT the) (NNS brains) (CC and) (NNS mandibles)) (VP=3 (VBN removed) (NP-2 (-NONE- *)))) (, ,) (CONJP (CC and) (RB then)) (S (NP-SBJ-5 (DT the) (NN skull)) (VP (VBD was) (VP (VBN fixed) (NP-5 (-NONE- *)) (PP-LOC (IN in) (NP (NML (CD 10) (NN %)) (NN NBF))))))) (. .)) )
( (S (S (SBAR-TMP (IN After) (S (NP-SBJ-1 (DT the) (JJ dorsoventral) (NN view)) (VP (VBD was) (VP (VBN taken) (NP-1 (-NONE- *)))))) (, ,) (NP-SBJ-2=5 (DT the) (NN head)) (VP (VBD was) (VP=4 (VBN bisected) (NP-2 (-NONE- *)) (ADVP-LOC (RB midsagittally))))) (CC and) (S (NP-SBJ-3=5 (JJ lateromedial) (NNS views)) (VP=4 (VBN taken) (NP-3 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (NNS Images)) (VP (VBD were) (VP (VBN taken) (NP-1 (-NONE- *)) (PP (IN on) (NP (DT a) (NML (NN MX) (HYPH -) (CD 20)) (NNP Faxitron) (NN X-ray) (NN machine) (PRN (-LRB- -LRB-) (NP (NP (NNP Faxitron) (NNP X-ray) (NNP Corporation)) (, ,) (NP-LOC (NNP Wheeling)) (, ,) (NP-LOC (NNP Illinois)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))) (PP (IN at) (NP (NP (CD 26) (NN kV)) (CC and) (NP (CD 0.3) (NN mA)))) (PP-MNR (IN with) (NP (NP (DT an) (NN exposure) (NN time)) (PP (IN of) (NP (CD 3) (NNS s))))))) (. .)) )
( (HEADING (NP (NN Immunohistochemistry) (. .))) )
( (S (NP-SBJ-1 (NP (NP (JJ Whole) (NNS embryos) (PRN (-LRB- -LRB-) (NP (NN E9.5) (, ,) (NN E10.5) (, ,) (NN E11.5) (, ,) (NN E12.5) (, ,) (NN E13.5) (, ,) (NN E16.5) (, ,) (CC and) (NN E18.5)) (-RRB- -RRB-))) (CC and) (NP (JJ adult) (NNS heads) (PRN (-LRB- -LRB-) (NP-TMP (NP (CD 13) (NNS DAB)) (CC and) (NP (CD 21) (NNS DAB))) (-RRB- -RRB-)))) (PP (IN from) (NP (NML (NML (JJ wild) (HYPH -) (NN type)) (CC and) (NML (NN Jbo) (HYPH /) (SYM +))) (NNS mice)))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN immunolabelling))))) (. .)) )
( (S (NP-SBJ-1 (NML (CD 3) (HYPH -) (NN μm)) (NN wax) (NNS sections)) (VP (VBD were) (VP (VP (VBN de-paraffinised) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN xylene) (NN substitute)))) (CC and) (VP (VBD rehydrated) (NP-1 (-NONE- *)) (PP-MNR (IN through) (NP (VBN graded) (NN ethanol) (NNS solutions)))))) (. .)) )
( (S (NP-SBJ-1 (NML (JJ Endogenous) (NN peroxidase)) (NN activity)) (VP (VBD was) (VP (VBN quenched) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (NML (CD 3) (NN %)) (NN hydrogen) (NN peroxide)) (PP-LOC (IN in) (NP (NN isopropanol))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS sections)) (VP (VBD were) (VP (VP (VBN microwaved) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (CD 10) (NNS mM)) (NN citrate) (NN buffer) (PRN (-LRB- -LRB-) (NP (NN pH6.0)) (-RRB- -RRB-))))) (CC and) (VP (VBN rinsed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (ADJP (NN phosphate) (HYPH -) (VBN buffered)) (NN saline)) (PP (IN at) (NP (NN room) (NN temperature)))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN immunostaining)) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT a) (NML (NNP Dako) (PRN (-LRB- -LRB-) (NP (NNP Glostrup) (, ,) (NNP Denmark)) (-RRB- -RRB-))) (NN autostainer)))) (PP (IN at) (NP (NN room) (NN temperature))))) (. .)) )
( (S (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO To) (VP (VB inhibit) (NP (DT the) (JJ non-specific) (JJ endogenous) (NN biotin) (VBG staining))))) (NP-SBJ-1 (DT the) (NNP Dako) (NML (NNP Biotin) (NNP Blocking)) (NNP System)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (VBG blocking) (NN solution)) (PP (IN of) (NP (NML (CD 10) (NN %)) (NN donkey) (NN serum))) (PRN (-LRB- -LRB-) (NP (NNP Serotec)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 1) (NN h))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Goat) (JJ polyclonal) (NN antibody)) (VP (VBN raised) (NP (-NONE- *)) (PP (IN against) (NP (NP (DT the) (NN carboxy) (NN terminus)) (PP (IN of) (NP (JJ human) (NN EVI1))))))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN concentration) (NML (NML (CD 1)) (PP (SYM :) (NP (CD 100)))) (PRN (-LRB- -LRB-) (NP (NP (NNP Santa) (NNP Cruz) (NNP Biotechnology)) (, ,) (NP-LOC (NNP Santa) (NNP Cruz)) (, ,) (NP-LOC (NNP California)) (, ,) (NP-LOC (NNP United) (NNP States))) (-RRB- -RRB-)))) (PP-TMP (IN for) (NP (CD 1) (NN h))))) (. .)) )
( (S (NP-SBJ-1 (NP (VBN Biotinylated) (NN donkey) (JJ anti-goat) (NN antibody) (PRN (-LRB- -LRB-) (NP (NNP Santa) (NNP Cruz) (NNP Biotechnology)) (-RRB- -RRB-))) (CC and) (NP (NNP ChemMate) (NN Detection) (NN Kit) (PRN (-LRB- -LRB-) (NP (NNP Dako)) (-RRB- -RRB-)))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB develop) (NP (DT the) (JJ specific) (NML (NN EVI) (HYPH -) (CD 1)) (NNS signals))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Negative) (NN control) (NNS sections)) (VP (VBD were) (VP (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NN donkey) (NN serum)))) (CC and) (VP (VBN processed) (NP-1 (-NONE- *)) (ADVP-MNR (RB identically))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS slides)) (VP (VBD were) (VP (VBN counterstained) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NN Haematoxylin))))) (. .)) )
( (HEADING (NP (JJ Skeletal) (NNS preparations) (. .))) )
( (S (NP-SBJ-1 (NNS Embryos)) (VP (VBD were) (VP (VP (VBN fixed) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (CD 95) (NN %)) (NN ethanol)))) (CC and) (VP (VBN processed) (NP-1 (-NONE- *)) (PP-MNR (IN through) (NP (DT a) (JJ standard) (NML (NML (NN alcian) (NN blue)) (CC and) (NML (NN alizarin) (NN red))) (NML (NN bone) (HYPH /) (NN cartilage)) (NN staining) (NN procedure)))))) (. .)) )
( (HEADING (NP (NP (NP (NN Immunology)) (CC and) (NP (NN FACS) (NN analysis))) (PP-LOC (IN in) (NP (JJ SPF) (NNS mice))) (. .))) )
( (S (S (NP-SBJ-1=2 (NP (DT The) (ADJP (NN T) (HYPH -) (JJ dependent)) (NN arm)) (PP (IN of) (NP (DT the) (JJ immune) (NN system)))) (VP (VBD was) (VP (VBN assessed) (NP-1 (-NONE- *)) (PP-MNR=3 (IN by) (NP (NP (NP (NN immunization)) (PP (IN with) (NP (NN keyhole) (NN limpet) (NN hemocycanin)))) (CC and) (NP (NP (NN measurement)) (PP (IN of) (NP (NN IgG1) (CC and) (NN IgG2a))))))))) (, ,) (CC and) (S (NP-SBJ=2 (DT the) (ADJP (NN T) (HYPH -) (JJ independent)) (NN arm)) (PP-MNR=3 (IN by) (NP (NP (NP (NN immunization)) (PP (IN with) (NP (NP (JJ pneumococcal) (NN polysaccharide)) (NP-ADV (NN type) (CD 3))))) (CC and) (NP (NP (NN measurement)) (PP (IN of) (NP (NN IgGM) (CC and) (NN IgG3))) (PP-LOC (IN in) (NP (NP (NML (QP (CD 42) (SYM –) (NN 56)) (HYPH -) (NNS DAB)) (JJ SPF) (NNS mice)) (-LRB- -LRB-) (NP (NP (CD ten) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD ten) (SYM +) (HYPH /) (SYM +)))))) (-RRB- -RRB-) (PRN (-LRB- [) (NP (CD 40)) (-RRB- ]))))) (. .)) )
( (S (PP (IN For) (NP (NN FACS) (NN analysis))) (NP-SBJ-1 (JJ whole) (NN blood)) (VP (VBD was) (VP (VBN collected) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN lithium) (NN heparin)) (NNS tubes))) (PP (IN from) (NP (DT the) (JJ jugular) (NN vein))) (PP-TMP (IN after) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG overdosing) (NP (NNS mice)) (PP-MNR (IN with) (NP (ADJP (NN barbiturate) (: -) (VBN administered)) (NN IP)))))))) (. .)) )
( (S (NP-SBJ-1 (JJ SPF) (NNS mice)) (VP (VBD were) (VP (VBN assessed) (NP-1 (-NONE- *)) (PP-TMP (IN at) (NP (NP (QP (CD 20) (SYM –) (CD 22)) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD 17) (JJ Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD 20) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (CC and) (NP (QP (CD 49) (SYM –) (CD 58)) (NNS DAB) (PRN (-LRB- -LRB-) (NP (CD 14) (NN Jbo) (HYPH /) (SYM +)) (, ,) (NP (CD 14) (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN FACS) (NN analysis)) (PP (IN of) (NP (NNS granulocytes)))) (VP (VBD was) (VP (VBN performed) (NP-1 (-NONE- *)) (PP-TMP (IN after) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG labeling) (NP (NNS cells)) (PP (IN with) (NP (NP (ADJP (NP (NN R) (HYPH -) (NN PE)) (HYPH -) (VBN labeled)) (NN Gr) (HYPH -) (CD 1)) (CC and) (NP (ADJP (NN FITC) (HYPH -) (VBN labeled)) (NML (NN Mac) (HYPH -) (CD 1)) (NNS markers))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNP Wilcoxon) (NML (NML (NNS sum)) (HYPH -) (PP (IN of) (HYPH -) (NP (NNS ranks)))) (NN test)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB test) (PP-PRP (IN for) (NP (NP (JJ statistical) (NNS differences)) (PP (IN between) (NP (NML (NML (NN Jbo) (HYPH /) (SYM +)) (CC and) (NML (SYM +) (HYPH /) (SYM +))) (NML (NML (JJ post-bleed) (NN antibody) (NNS titers)) (CC and) (NML (NN granulocyte) (NNS parameters)))))))))))) (. .)) )
( (HEADING (NP (VBG Supporting) (NN Information))) )
( (HEADING (NP (NN Table) (NN S1))) )
( (HEADING (NP (NP (ADJP (ADJP (NN T) (HYPH -) (JJ Dependent)) (CC and) (ADJP (NN T) (HYPH -) (JJ Independent))) (NNS Responses)) (PP-LOC (IN in) (NP (ADJP (NN Immune) (HYPH -) (VBN Challenged)) (NML (NML (JJ Wild) (HYPH -) (NN Type)) (CC and) (NML (NN Junbo))) (NNS Mice))))) )
( (CAPTION (NP (-LRB- -LRB-) (NML (CD 35) (NN KB)) (NN DOC) (-RRB- -RRB-))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Click) (ADVP (RB here)) (PP (IN for) (NP (JJ additional) (NNS data) (NN file)))) (. .))) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ (PRP We)) (VP (VP (VBP thank) (NP=1 (NNP Dr.) (NNP Emma) (NNP Coghill)) (PP-PRP=2 (IN for) (NP (NP (NN advice)) (PP (IN on) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NNP Amera) (NN software)))))))) (CC and) (VP (NP=1 (NNP Stuart) (NNP Townsend)) (PP-PRP=2 (IN for) (NP (NP (NN assistance)) (PP (IN with) (NP (NN FACS) (NN analysis))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VBP thank) (NP (DT the) (NML (NNP Histology) (CC and) (NNP Pathology)) (NNS teams)) (PP-LOC (IN at) (NP (NP (NNP Harwell)) (, ,) (NP-LOC (NNP United) (NNP Kingdom)))) (PP-PRP (IN for) (NP (NP (NN processing)) (PP (IN of) (NP (NNS specimens)))))) (. .)) )
( (HEADING (NP (NNS Abbreviations))) )
( (NP (NP (NNS DAB)) (: -) (NP (NP (NNS days)) (PP-TMP (IN after) (NP (NN birth))))) )
( (NP (NP (NNS dpc)) (: -) (NP (NP (NNS days)) (ADVP-TMP (RB postcoitum)))) )
( (NP (NP (NN ENU)) (: -) (NP (NN N) (HYPH -) (NN ethyl) (HYPH -) (NN N) (HYPH -) (NNS nitrosourea))) )
( (NP (NP (NN MEC)) (: -) (NP (NML (JJ middle) (NN ear)) (NN cavity))) )
( (NP (NP (NN NTHi)) (: -) (NP (JJ nontypeable) (NN Haemophilus) (NNS influenzae))) )
( (NP (NP (NN OM)) (: -) (NP (NN otitis) (NNS media))) )
( (NP (NP (JJ SPF)) (: -) (ADJP-TTL (NP (JJ specific) (NN pathogen)) (HYPH -) (JJ free))) )
( (HEADING (NP (NNS Footnotes))) )
( (HEADING (NP (VBG Competing) (NNS interests) (. .))) )
( (S (NP-SBJ-1 (NP (NN Part)) (PP (IN of) (NP (DT this) (NN work)))) (VP (VBD was) (VP (VBN funded) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NNP GlaxoSmith) (HYPH -) (NNP Kline))))) (. .)) )
( (HEADING (NP (NN Author) (NNS contributions) (. .))) )
( (S (NP-SBJ (NNP NP) (, ,) (NNP REHH) (, ,) (NNP HT) (, ,) (NNP ND) (, ,) (NNP AJH) (, ,) (NNP MTC) (, ,) (CC and) (NNP SDMB)) (VP (VBD conceived) (CC and) (VBD designed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP NP) (, ,) (NNP REHH) (, ,) (NNP HT) (, ,) (NNP HTT) (, ,) (NNP DB) (, ,) (NNP SM) (, ,) (NNP ZL) (, ,) (NNP FM) (, ,) (NNP MF) (, ,) (NNP PG) (, ,) (NNP AMW) (, ,) (NNP SP) (, ,) (NNP IB) (, ,) (NNP TAH) (, ,) (CC and) (NNP MTC)) (VP (VBD performed) (NP (DT the) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP NP) (, ,) (NNP REHH) (, ,) (NNP HT) (, ,) (NNP HTT) (, ,) (NNP DB) (, ,) (NNP SM) (, ,) (NNP ZL) (, ,) (NNP FM) (, ,) (NNP ND) (, ,) (CC and) (NNP MTC)) (VP (VBD analyzed) (NP (DT the) (NNS data))) (. .)) )
( (S (NP-SBJ (NNP MF) (, ,) (NNP PG) (, ,) (NNP AMW) (, ,) (CC and) (NNP SP)) (VP (VBD contributed) (NP (NP (NNS reagents)) (HYPH /) (NP (NNS materials)) (HYPH /) (NP (NN analysis) (NNS tools)))) (. .)) )
( (S (NP-SBJ (NNP NP) (, ,) (NNP REHH) (, ,) (NNP MTC) (, ,) (CC and) (NNP SDMB)) (VP (VBD wrote) (NP (DT the) (NN paper))) (. .)) )
( (HEADING (NP (NN Funding) (. .))) )
( (S (NP-SBJ-1 (DT This) (NN work)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NNP Medical) (NNP Research) (NNP Council)) (, ,) (NP-LOC (NNP United) (NNP Kingdom)))))) (. .)) )
( (S (NP-SBJ-1 (NNP Hilda) (NNP Tateossian)) (VP (VBZ is) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NNP Eumorphia) (NN program) (PRN (-LRB- -LRB-) (NP (NML (NNP European) (NNP Commission) (NN contract)) (NN QPG2) (HYPH -) (NN CT) (HYPH -) (CD 2002) (HYPH –) (CD 00930)) (-RRB- -RRB-)))))) (. .)) )
